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EXECUTIVE SUMMARY 
The impact of the HIV pandemic in Tanzania has been profound and has 
affected all sectors. Today, HIV/AIDS is recognized not only as a major public 
health concern but also as social, economic and development problem in 
Tanzania as in most in Sub-Saharan African countries. With a population of 
estimated 37 million, Tanzania has an estimated of 2.5 million people infected 
with human immunodeficiency virus (HIV). 
The availability of antiretroviral therapy (ART) which has been defined as the 
main form of treatment (yet not a cure) for HIV/AIDS showed to significantly 
prolong and improve quality of life of people infected with HIV. 
By and large, the entire range of antiretroviral drugs is available anywhere in the 
world through private channels. Where resources permit, the supply may be 
adequate and consistent. Through the public sector, however, and for low-
income patients, the choice of drugs may be somewhat restricted. This has 
implications for decisions such as when to start therapy, which therapeutic 
regimens to use, and what to do when treatment fails. 
The situation requires difficult choices in priority setting, poses serious ethical 
issues and imposes on government the obligation to scale up programmes in 
ways that are ethically sound, equitable, beneficial and sustainable as possible 
(WHO 2004). However in Tanzania, there is no clear policy established on 
targeting or prioritising specific population groups in order to avoid decision 
making based on subjective or arbitrary criteria that may lead to discrimination. 
The aim of this study was to establish the socioeconomic status of those 
individuals who benefit most from the provision of free ARV in terms of utilisation 
in urban and rural settings. It also aimed to identify the criteria used in enrollment 
of patients for free ARV provision, the barriers for ARV provision and patient's 

















A cross-sectional study was conducted to collect the data on the socio-economic 
status of HIV patients who access antiretroviral therapy in selected ARV clinics in 
Tanzania. The study was carried out in the urban district hospitals of Dar es 
Salaam region and the rural district hospitals of Kagera region. Closed-ended 
questionnaires, focus group discussions (FGD) and key informant interviews 
were the main instruments. The socioeconomic status of patients receiving free 
ARV was captured through facility based questionnaires with closed-ended 
questions about gender, age, education, employment status, living conditions 
and household assets. 
These questions were synchronized with the Tanzania Demographic and Health 
Survey (TDHS 1999). The questions allowed the comparison of the data set from 
questionnaires to that from the TDHS for the analysis of the study. Other 
questions concerning the knowledge, altitude, and practice around ARV were 
also asked. An asset index was constructed based on information on household 
ownership of durable goods and housing characteristics using principal 
components analysis (PCA). 
The main findings from this study showed that, 
• Overall, the uptake of free antiretroviral treatment in public facilities in 
Tanzania is relatively higher within the less poor population groups. This 
pattern is more pronounced in urban areas than rural areas. In Dar es 
Salaam district hospitals, ART uptake increases with wealth, while in 
Kagera free ART is skewed towards the lowest and the highest quintiles. 
• Yet, those with no education or with only primary education are well 
represented, relative to the patterns of education reflected in the TDHS. 
The findings also show a relatively high uptake of ART among the 
unemployed, among women and within the "productive" age groups. The 
study, however, could not assess utilisation with respect to health care 
needs. 
vii 
Based on the above findings, one can conclude that targeting of free ARV 
provision in Tanzania should be improved. It is hoped that the findings from the 
study will help policy makers to set clear policy guidelines, which prioritise 
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CHAPTER ONE: INTRODUCTION AND BACKGROUND 
1.1 Introduction 
HIV/AIDS is one of the major public health problems with adverse effects on the 
socio-economic development of many developing countries. Current statistics 
indicate that over 42 million people are infected with HIV among whom over 27 
million are in sub-Saharan Africa (WHO 2004). The epidemic has claimed almost 
19 million lives over the past two decades including 4 million children. Further, 
the epidemic is one of the contributing factors to orphaned children. Studies 
indicate that HIV/AIDS has left over 15 million children orphaned in its wake 
(WHO 2004). Sub-Saharan Africa is the world's most severely affected region, 
with only 1 0% of the world's population it harbours about two thirds of the global 
total number of people living with HIV and AIDS (WHO 2004). One in 12 adults in 
this region is reported to be infected with HIV. According to Laurent et al. (2002), 
in sub-Saharan Africa, HIV/AIDS is the leading cause of adult deaths. In the year 
2000 alone, an estimated 2.4 million out of the global total of 3 million adult and 
child deaths from HIV/AIDS occurred in the African region. 
Tanzania is one of the highly affected countries in Sub-Saharan Africa with about 
2.5 million people infected with HIV and an estimated prevalence of 9.6% (NACP 
2005). The first acknowledged cases of AIDS were diagnosed in the Kagera 
region of Tanzania in 1983. HIV/AIDS was initially seen as just a health issue, 
and the initial response was from the Ministry of Health (MOH). In 1985 the MOH 
formed an HIV/AIDS technical committee to advice on diagnosis, treatment and 
prevention of the disease. This resulted into inception of Tanzania's National 
AIDS Control Program (NACP). The formation of the National AIDS Control 
Programme (NACP) under the Ministry of Health in 1985 was one of the 
Government's responses to slow the spread of HIV/AIDS in Tanzania. The NACP 
started with a two-year phase called Short Term Plan (1985-1986). Subsequent 
phases were termed Medium Term Plans (MTP) lasting for five-year periods 
beginning with MTP-1 (1987-1991), followed by MTP-11 (1992-1996) and MTP-111 
] 
(1998-2002) (NACP 2005). All of these phases aimed at developing strategies to 
prevent, control and mitigate the impact of the HIV/AIDS epidemic through 
decentralization, multi-sector response and community participation. 
The NACP subsequently established District AIDS Coordinators (DACs) in every 
district in the country. In addition, the National AIDS Advisory Board (NAAB) was 
established in 1999, and later the Tanzania Commission for HIV/AIDS 
(TACAIDS) was established on December 1 (World AIDS Day), 2000. TACAIDS 
was formed by the President and became legally established in November 2001. 
As the epidemic grew, it was realized that HIV/AIDS was not only a health 
problem but a wider development problem. 
As more sectors realized the importance of the disease in their workplaces and 
its effect on their development processes, more actors joined to fight the 
epidemic. In addition, there are a significant number of non-governmental 
organizations (NGOs) in nearly every district that are playing important roles in 
combating the HIV/AIDS pandemic. Recent data based on household surveys 
estimate the sera-prevalence in adults in Tanzania to be 9.6%, with a wide 
variation across the regions. The disease is the major public health problem and 
poses a development crisis that affects health, economic and social progress, 
reducing life expectancy, deepening poverty and contributing to exacerbating 
food shortage (UNAIDS 2004). 
Current age and gender distributions of reported HIV/AIDS cases reveal that the 
disease has the strongest impact on individuals in the prime of their working and 
child-bearing years, from 20-49 years, who thus have a limited capacity to make 
a productive contribution to society. The pattern shows early infection of young 
women, with reported cases peaking from age 25-34, while in men the majority of 
cases occur slightly later in life, peaking at 30-39 years (UNAIDS 2004). 
These groups are unable to play an active economic role or provide for their 
families in their advanced stages of the diseases (e.g. WHO stage IV). By 2001 
they had left behind an estimated 810,000 children orphaned due to HIV/AIDS, 
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putting additional pressure on the limited resources of their extended families and 
communities. 
There have been various initiatives to increase access to life saving antiretroviral 
drugs. In 2003, the Tanzanian Ministry of Health (MOH) in collaboration with 
other stakeholders, formulated a comprehensive HIV/AIDS policy which sets out 
the framework for scaling up health sector response to HIV/AIDS and for 
increasing access to affordable and essential interventions for prevention, 
treatment, care and support for HIV/AIDS patients (GOT/MOH/NACP 2003). 
This study is based on the assumption that socio-economic status is one of the 
main determinants of exposure to HIV/AIDS with poverty and social inequalities 
leading cofactors in HIV transmission. Therefore reaching the vulnerable groups 
(low socio-economic status) for awareness, prevention and treatment of HIV is 
more than important. 
In Tanzania, socio-economic inequalities in utilisation of health care and in health 
outcomes are large and even within a rural society that might easily be assumed 
to be uniformly poor (Schellenberg et al. 2003). This suggests that the poor have 
benefited less than the better off from publicly provided health services due to 
either some financial barriers or user dissatisfaction. The policy response to this 
undesirable situation has been to improve the quality of health services provided 
by public facilities; however it is still not yet clear whether the poor are benefiting 
or not. 
Therefore, this study intends to identify the socioeconomic status of individuals 
utilizing the free antiretroviral therapy (ART) in public facilities in Tanzania. Its 
focus is to help answer the question of who are the beneficiaries of the publicly 
financed antiretroviral programs i.e. whether it is the poor or non-poor. It will also 




1.1.2 HIV transmission 
The HIV infection is acquired through sexual intercourse with an infected partner; 
exposure to infected blood and blood products; from an infected mother to the 
unborn child in the uterus during delivery or from breast milk. More than 90% of 
adults in sub-Saharan Africa acquire HIV infection from unprotected sexual 
intercourse with infected partners (WHO 2004). Transmission of HIV through 
body fluids other than blood and genital secretions such as cerebral spinal fluid 
(CSF), pleural fluid, amniotic fluids is certainly possible. However, to date there 
are no reported cases of HIV transmission resulting from exposure to saliva, 
urine or sweat suggesting that the risk of an individual acquiring infection from 
these body fluids is minimal if any. 
Interaction between the viral envelope proteins (gp 120) and receptors on the cell 
membrane is critical for the HIV to enter and infect the host cell (NACP, 2005). 
High concentration of the CD4+molecules and co-receptors has been detected 
on the surface of T-lymphocytes and macrophages. Other cells that have been 
found to have CD4+ molecules on their surface include the langerhans cells 
(found in the skin) and the microglial cells of the brain. Initial infection with HIV is 
characterized by a relatively brief period of high level acute virus replication. This 
is sometimes marked by the development of flu like illness with fever, malaise, 
enlarged lymph nodes, sore throat, skin rash or joint pains. This acute febrile 
illness (sera-conversion) is accompanied by widespread dissemination of the 
virus to different tissues especially the lymphoid system that is extensively 
involved. HIV blood tests that are designed to detect presence of HIV antibodies 
are usually not yet positive at this point in time. However, such patients are highly 
infectious although they test negative for HIV using the common test that depend 
on detection of antibodies against HIV. The high level of viraemia (virus in blood) 
present at the time of sero-conversion may persist for about three months but 
eventually stabilizes at an individual set point. The number of RNA copies/ unit 
volume (viral load) is an indicator of disease activity. Nevertheless most patients 
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are clinically asymptomatic in spite of this ongoing extensive immunological 
battle (MOH, 2004) 
During this asymptomatic phase of the infection, levels of CD4+ T-lymphocytes, 
the prime target of HIV gradually decline although the rate of decline varies 
substantially among patients. Major factors that are known to influence the rate of 
CD+ T-lymphocytes decline include patient's genetic factors, viral load (number 
of HIV-RNA copies/unit volume) at the set point, age and viral characteristics. 
This stage (WHO stage 1) may last for an average of 8-1 0 years and is free of 
symptoms although there may be swollen glands (persistent generalized 
lymphadenopath-PG L). 
Over time, the immune system loses the struggle to contain HIV and so 
symptoms develop. Symptomatic HIV infection is often caused by the emergence 
of opportunistic infections. The commonest problems include fever, respiratory 
infections, cough, tuberculosis, weight loss, skin diseases, viral infections, oral 
thrush, pain and lymphadenopathy. This stage is WHO stages 2 and 3 
depending on the particular opportunity infections seen. 
The diagnosis of AIDS is confirmed if a person with H IV develops one or more of 
a specific number of severe opportunistic infections or cancers (WHO stage 4). 
Such conditions include Kaposi's sarcoma, Cryptococcus meningitis, 
Toxoplasmosis, pneumocystic carnii pneumonia (PCP) and cytomega-virus 
renitis (CMV-renitis). 
1.1.31mpact of HIV/AIDS in Tanzania 
The impact of the HIV epidemic has affected all sectors; hence HIV/AIDS is 
recognized not only as a major public health concern, but also as socio-economic 
and developmental problem in Tanzania (NACP 2005). 
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Health impact 
In many developing countries including Tanzania, the increasing HIV epidemic 
has impacted significantly on already weakened public health services. The 
HIV/AIDS pandemic has interacted with other underlying public health problems 
most notably tuberculosis (NACP 2005). It is now believed that TB is the main 
cause of death in people with HIV infection because HIV is the strongest factor 
capable of promoting progression of mycobacterium tuberculosis (MTB) infection 
to active tuberculosis both in people with recently acquired and latent MTB 
infections (NACP 2005). This explains why the rate of TB in many African 
countries has gone up regardless of their well organized TB control programs. In 
some countries, up to 70% of patients with sputum smear-positive pulmonary TB 
are HIV-infected (MOH 2005). According to NACP 2005 report, most urban 
district and regional hospitals in Tanzania report a bed occupancy rate (IP 
admissions) of up to 50-60% for HIV related conditions. This has led to reduction 
in resources available for other health problems hence seriously affecting quality 
of health care services delivered. Also, health care personnel are affected by the 
pandemic resulting in the shortage of human resource in hospitals. 
Economic impact 
The relationship between HIV/AIDS and economic development is complex. 
HIV/AIDS negatively affects economic growth on the one hand and a weak 
economy makes it difficult for nations and individuals to mount adequate and 
comprehensive responses to the epidemic on the other. In addition, reports from 
UNAIDS 2004, show that poverty is a powerful cofactor to the spread of 
HIV/AIDS. The economically and socially disadvantaged, women, youth and 
other marginalized groups in the society, are disproportionately affected by the 
epidemic. These groups are unable to play an active economic role or provide for 
their families. By 2001 they had left behind an estimated 810,000 children 
orphaned due to HIV/AIDS, putting additional pressure on the limited resources 
of their extended families and communities (UNAIDS, 2004). Ill health and death 
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due to AIDS are reported to have reduced agricultural labour force, productivity 
and disposable incomes in many families and rural communities. 
There are two major economic effects due to HIV pandemics; reduction in the 
labor supply and increased costs. In labor supply, it means the loss of young 
adults in their most productive years affects overall economic output. In terms of 
increased costs, there is a direct cost including expenditure on health care 
services, drugs and funeral expenses and indirect costs include lost time due to 
illnesses, recruitment and training costs to replace workers and care of orphans. 
These costs lead to a significant reduction in already weakened economic 
growth. 
Data from Kagera, one of the regions most severely affected by H IV I AIDS in 
Tanzania, indicate that the annual Gross Domestic Product (GOP) declined from 
USD 268 to USD 91 between 1983 and 1994 respectively (GOT 2002). The 
report said that, although the decline in GOP was multi-faceted, HIV/AIDS was 
believed to be a major cause. The similar trends of declining GOP were 
associated with reduced agricultural population and increase in number of AIDS 
cases in Tanga region. 
Social impact 
Studies conducted in Arusha, Kagera and Mwanza regions showed a serious 
and growing breakdown of social networks, which have hitherto sustained African 
societies (GOT 2002). Orphans are not only subjected to material, social and 
emotional deprivation, but also to lack of opportunities for education and health 
care. It was showed that, an increased expenditures and reductions in income 
led to withdrawal of children from school in order to reduce education-related 
expenditures and also to have children help with household chores. The indirect 
and direct costs due to HIV/AIDS have led to many households to sell their 
properties in order to pay for these costs. These poor families do not recover to 
their initial standard of living when productive household members die. Also the 
study showed that widows and orphans are deprived of their inheritance rights by 
relatives through the application of outdated traditional practices and customary 
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taws. The widows are often blamed for the premature deaths of their husbands. 
However, the above challenges can be stabilized or even reversed given the well 
organized programs in the country context. 
1.2 Problem identification 
Evidence on public spending for health summarized by Filmer (2003) shows that 
the services (loosely categorized as primary health care) which tend to focus on 
infectious diseases and on other maternal and child health issues that are 
particularly prevalent among disadvantaged groups favour the better off less than 
is the case for secondary and tertiary care. But although such services may 
generally be Jess pro-rich than others, only rarely are they pro-poor. Additional 
evidence comes from 45 Demographic and Health Survey (DHS), analyzed by 
the World Bank (Gwatkin et at. 2000) which indicate that, even services often 
given high priority in the name of equity (for example oral rehydration for 
childhood diarrhoea, attended delivery and clinical immunization ) are more likely 
to be captured by the well off than by the poor. 
According to many studies conducted on ARV treatment in developing countries, 
the majority of patients usually start ARV treatment at an advanced stage of HIV 
disease. In one treatment centre in Ivory Coast, 55% of patients were in CDC 
category 3 (advanced disease) at the start of treatment, in Senegal this 
proportion was 75%, while 68% of the patients at the Mildmay centre in Uganda 
had advanced disease at the start of therapy (WH0,2004). This is due to a 
combination of factors such as late care seeking through fear or denial, a Jack of 
accessible counseling and testing services so that many people are unaware of 
their HIV infection and the high cost of the drugs which leads to treatment being 
deferred. 
By and large, the entire range of antiretroviral drugs is available anywhere in the 
world through private channels. Where resources permit, the supply may be 
adequate and consistent. Through the public sector, however, and for tow-
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income patients, the choice of drugs may be somewhat restricted. This has 
implications for decisions such as when to start therapy, which therapeutic 
regimens to use, and what to do when treatment fails (WHO 2004). 
One of the goals of the Tanzania Care and Treatment Five-year Plan (NCTP 
2003) is to "increase access of ARVs to HIV patients, provide quality, continuing 
care and treatment to as many HIV positive residents of the United Republic of 
Tanzania as possible, building one of the careful planning already completed by 
the Ministry of Health and the Tanzania commission for AIDS" (GOT/MOH 
2003:21). 
The plan recommends that the treatment be made available through established 
care and treatment clinics. It further proposes maximal integration within the 
existing healthcare infrastructure, local planning, efficient use of available 
resources, increasing the number of VCT centres, fast creation of PMTCT 
programmes in all antenatal clinics, and an expansion of routine counselling and 
testing of all patients in the healthcare system regardless of their reason for entry 
(GOT/MOH 2003). 
The total budget to implement the plan is estimated at USD 539 million over 5 
years, with most of the cost (68%) occurring in the final two years of scaling up. 
However, so far the government has been unable to raise the amount necessary 
to ensure that the target will be reached (GOT/MOH 2003). Currently, it is 
estimated that only 13,000 HIV patients are on the public ARV provision 
programme with 96 sites which provide the services in the country (MOH 2004). 
This is a small number compared to the HIV positive population, but due to 
financial constraints, government is unable to expand the programme. 
The Government of Tanzania, with donor support, has a plan of putting more 
than 400,000 people living with HIV/AIDS on antiretroviral (ARVs) within a five 
year period, of which 65,150 will be treated by the end of 2005 (GOT/MOH, 
2003). Furthermore, the Tanzania Food and Drug Authority (TFDA) registered 
more than 50 antiretroviral formulations enabling private pharmaceutical 
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companies and hospitals to stock and sell ARVs (TFDA 2004). This indicates the 
commitment of the Government and other stakeholders to increase access to 
ARVs for people living with HIV in Tanzania. 
The situation requires difficult choices in priority setting, poses serious ethical 
issues and imposes on government the obligation to scale up programmes in 
ways that are ethically sound, equitable, beneficial and sustainable as possible. 
One way to address this challenge is to set criteria to decide who to receive 
these life saving medicines. Some of the criteria are clinical features, such as a 
CD4 count below 200 cells/mm3, World Health Organisation stage 4, and the 
patient's willingness, readiness and ability to adhere to ART (MOH 2005; WHO 
2004). However in Tanzania, there is no clear policy established on targeting or 
prioritising specific population groups in order to avoid decision making based on 
subjective or arbitrary criteria that may lead to discrimination. 
According to WHO 2004, special care has to be taken to ensure and monitor 
access for the vulnerable, poor and marginalized populations. The Tanzanian 
Household Budget Survey 2002 confirms that income poverty is high and social 
indicators are usually poor. It also points to large gaps between different groups 
and the biggest gap is between rural and urban populations i.e. rural households 
are much poorer than their urban equivalents in almost all aspects. However, the 
need to focus on reducing poverty in rural areas remains compelling. For 
example, in rural Tanzania, 75% of the population live below the poverty line, and 
hypotheticaly these are the ones who suffer more with HIV/AIDS because they 
lack the necessary information on HIV transmission as they are illiterate and 
have no access to all services provided by government including proper use of 
condoms, existence of ARV, and different health education programmes through 
the media regarding dangers of high risk behaviour. This is reflected in the 
statement by the ART-LINC Study Group (2005) that the inverse equity 
hypothesis applies, which stipulates that health inequities will get worse as 
effective new public health interventions initially reach those of higher 
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socioeconomic status and only later the poor may therefore be borne out in the 
case of HAART in resource-poor setting. 
It is therefore important to understand how health providers are deciding who 
should receive treatment and who are the socio-economic groups actually 
benefiting from free/ subsidized ARV provision through public health facilities in 
Tanzania. 
1.3 Rationale/ justification of the study 
This study is clearly important in a developing country where the HIV epidemic is 
expected to have a dramatic impact on life expectancy and lead to early mortality 
for a large proportion of the population. Average life expectancy in Sub-Saharan 
Africa is now 47 years, when it could have been 62 years without the AIDS 
pandemic (WHO 2004). 
Highly Active Antiretroviral Therapy (HAART), a combination of at least three 
drugs has substantially improved the prognosis of HIV-infected patients in 
industrialized countries. In resource -poor setting in Africa, Asia and South 
America where 90% of people with HIV/AIDS live, access to HAART continues to 
be limited. It is estimated that one million HIV-infected individuals presently 
receive HAART in low and middle income countries which represents only 15% 
of the 6.5 million people urgently in need of such treatment in these settings 
(ART-LING Study Group 2005). Currently, there are no fixed dose combination 
for second line therapy ( patients move from one pill twice a day up to 15 pills 
daily) and the price can be as much as 1 0-20 times higher than a generic first 
line regimen. For example in Cameroon, the first line therapy costs US $ 277 per 
year while the second line therapy is over US$ 4000 (Calmy et al. 2004). The 
treatment of children poses a particular challenge. Because of lack of 
commercial interest (few paediatric cases in western countries), some 
manufacturers of ARV drugs do not produce paediatric formulation at all (Calmy 
et al. 2004). Some molecules are marketed without even having been tested for 
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use in children (e.g. tenofovir) and those paediatric formulations that are 
produced are generally more expensive. While the fixed dose version for adults 
is available for about US$ 200 per patients per year, the best price for the same 
drugs in paediatric formulations is about US$ 1300 (oral solutions and syrups). 
The "3 by 5 "initiative launched by the World Health Organization (WHO), the 
joint United Nations Programme on HIV/AIDS, including the Global Fund to Fight 
AIDS, TB and Malaria (GFATM), and the US President's Emergency Plan For 
AIDS Relief (PEPFAR) provide additional hope that millions of people with 
HIV/AIDS will have access to life saving treatment in the coming years (WHO 
2004). Within this initiative free ARVs would be provided through public health 
care institutions ensuring that not only will the poor not be excluded from the 
scaling up of ART, but also priority will be given to them by making drugs 
available and affordable. 
Although ART has been shown to be effective in poor settings (Laurent et al. 
2002) and poor HIV patients have demonstrated their potential to be adherent to 
therapy, there has been very little primary research on how the poor benefit from 
the ART provision. Specifically in Tanzania, there are no studies been done to 
find out how these poorest of the poor do benefit from ARV provisions in public 
facilities. 
The purpose of this research is to fill this gap. Specifically, there is a focus on the 
socio-economic status of those accessing ARV drugs in terms of perception of 
ARV provision, the productivity gain after taking ARV and the barriers to ARV 
provision. The findings of this study will help policy makers in Tanzania to set 
clear policy guidelines, which prioritise vulnerable, poor and marginalised groups 
of the population. 
12 
1.4 Study objectives 
The main objective of this study is to determine to what degree poor and 
vulnerable groups in Tanzania benefit from the provision of antiretroviral 
treatment. 
The specific objectives are: 
I. To evaluate the criteria considered by managers and providers for 
eligibility to access antiretroviral treatment free of charge. 
II. To establish the socio-economic and demographic characteristics of those 
utilising the free ARV drugs. 
Ill. To compare the socio-economic and demographic characteristics of those 
utilising free ARV drugs to those of the overall population and the 
respective utilisation rates. 
IV. To determine whether the poor have enough information about ARV on 
side effects, appropriate doses and time to start ART (knowledge and 
attitude towards ART) 
Table 1 provides an overview of the study objectives, data or information that 
were needed and the source of the data/information for each objective 
13 
Table 1: Study objectives, Data Requirements & Sources 
Objectives Information/ data needed Tool/source 
1) To evaluate the criteria Objectives of ARV roll- out Interviews with key 
considered by providers informants (MOH, 
for eligibility to access TACAIDS, NACP and 
ARVs free of charge other local NGOs) 
2} To establish the socio- Asset-based index including: Interviews with key 
economic characteristics Location informants (MOH, 
of those utilising ARV Source of drinking water TACAIDS, NACP and 
drugs. Availability of electricity other local NGOs). 
Sanitation facilities Structured 
Building materials questionnaire 
Possession of valuable and interviews with HIV 
Durable goods patients on ARVs. 
3) To compare the socio- Asset-based index including: Structured 
economic status of those Location questionnaire 
utilising ARVs to those of Source of drinking water, interview with HIV 
the overall population and Availability of electricity, patients on ARVs. 
to determine the Sanitation facilities, Tanzania Demographic 
respective utilisation rates. Building materials of and Health Survey 
dwellings, (TDHS 1999} 
Possession of valuable 
and durable goods. 
The following socio-
economic variables will 






4) To determine how the Qualitative data on the Interview with patients 
poor perceive provision of knowledge levels and on ART based on a 
ARV attitudes towards ART. structured 
Quantitative data to compare the questionnaire; 
perception of the poor vs. the focus group 
perception of the community as discussions. 
a whole. 
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CHAPTER TWO: ANTIRETROVIRAL TREATMENT IN TANZANIA'S PUBLIC 
SECTOR 
2.1 Overview 
This chapter will provide the Tanzanian context, including the demographic and 
socio-economic structure of the country. The health structure within the country 
and the health status of the population will be described. Lastly, the ARV 
programmes, types of antiretroviral treatment available in the public sector in 
Tanzania and the World Health Organization (WHO) recommendations will be 
discussed. 
2.2 Country context 
The United Republic of Tanzania, situated in East Africa, has an area of 
945,087 sq km, divided into 26 regions, and has a total population of 36,977,000 
with the annual population growth rate of 2.5%. Each region has at least four 
districts. The GDP per capita is International $ 630 (NHA, 2002). 
According to the latest Household Budget Survey (HBS) 2001/2002, there has 
been a modest improvement in economic growth. The economy has diversified 
and household consumption has increased. The proportion of the population that 
is poor has fallen slightly, although the absolute number has risen due to the 
population growth (Demombynes and Hoogveen 2002). The improvements have 
been concentrated in urban areas particularly Dar es Salaam while they have 
been more limited in rural areas where the majority (about 75%) of Tanzanians 
live. There is a concern that the rapid growth may not be substantially reducing 
poverty and rather is associated with rising inequality where about 87% of the 
poor in Tanzania live in the rural areas. This is supported by the Household 
Budget Survey (HBS) 2002, which shows a rise in Gini coefficient from 0.34 in 
1995 to 0.35 in 2002. Poverty levels are strongly related to the education of the 
head of the family. The survey showed that, some 51% of individuals are poor if 
the head has no education compared with only 1 %when the head is educated 
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above primary education level. The percentage of adult literacy is 71% where 
29% can neither read nor write. Very few adults in rural areas have been 
educated above primary education level. (Household budget survey (HBS) 
2001/2002). The inequality also exist in education among men and women, 
where women are about twice as likely as men to have no education and 41% 
are unable to read and write (HBS 2001/2002). The rise of the private sector in 
Tanzania has caused a drop in government and parastatal employment from 
5.2% to 2.5% of adults (NHA 2002). 
However the HBS 2001/2002 show the large gap between the above different 
groups, the biggest gap is obvious between urban and rural populations. To fill 
this gap, the sustained growth in rural GDP and reduction in the rate of 
population increase is highly required. 
2.3 Health system and health status in Tanzania 
The health system in Tanzania has a pyramidal pattern of a referral system 
recommended by health planners, which is from dispensary to consultant 
hospital. It is structured at various levels of health care delivery and services as 
follows: Village health services form lowest level of health care delivery and 
services can be offered in homes. The dispensary services cater for between 
6000 to 10000 people while the health centre services cater for about 50000 
people. Each district has at least one district hospital and every region has a 
regional hospital with specialist in various fields and offers more services than 
district hospital. The referral consultant hospital is the highest level of hospital 
services in the country and there are 4 referral hospitals in the country, which 
caters for all zones, Eastern, Northern, western and Southern zones. 
Generally, the health status of the people in Tanzania is poor. The infant 
mortality rate (IMR) is 99 per 1000 live births, the under-5 mortality rate is 160per 
1000, the maternal mortality rate is 800 per 1 00,000 births, and the average life 
expectancy is 48 years (WHO, 2004). However, 71% of children between 12-23 
months are fully vaccinated (EPI, 2004). Contraceptive prevalence remains very 
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low in Tanzania, which causes the annual population growth rate (2.5%) to be 
one of the highest in Africa (Government of Tanzania 2002). About 7% of married 
women overall use modern methods of contraception which compares with rates 
of 28% and 36% for Uganda and Kenya respectively (WHO 2004). 
Like other sub-Saharan countries, malaria, HIV/AIDS, Tuberculosis, diarrhoea 
contribute to high morbidity and mortality figures in Tanzania. These problems 
are unevenly distributed between urban and rural populations, between children 
and adults and between well-educated and non-educated citizens. The most 
affected are the majority of the total population, which is the rural citizen (75% of 
the total population), children under 15 years (47% of the population) and none 
educated citizens (56% of the total population) (World Bank 2003). 
As it was stated above, the level of poverty (illiteracy, unemployment) 
hypothetically is the underlying reason of the burden of the disease. Also the 
quality of health facilities is often poor due to lack of trained/motivated personnel, 
lack of drugs, and lack of functioning equipments, even if the number of facilities 
is not low (Munish et al. 2001 ). 
The total expenditure on health as a share of GDP is 4.9 percent and per capita 
expenditure on health is international dollars 31 $. 83% of private expenditure on 
health is out of pocket (NHA 2002). This figure implies a financing system that is 
overall regressive. 
2.4 ARV programme in Tanzania 
One of the most effective interventions currently available for people living with 
HIV/AIDS involves the use of various combinations of highly active antiretroviral 
therapies (HAART). However, the high costs of these drugs and the 
infrastructure needed to monitor their use have so far put these medications 
beyond the reach of most PLHA in Tanzania. 
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The Government of Tanzania adopted the National HIV/AIDS Care and 
Treatment Five Year Plan (NCTP) in October 2003. The implementation of the 
plan is ongoing. Strengthening the health infrastructure is one of the four key 
goals of the plan. The NCTP describes a strengthening and certification 
procedure in order to assess, upgrade and certify facilities, to have them become 
ready for quality HIV/AIDS care and treatment. 
Minimum criteria were identified and a site assessment tool was developed in 
order to assess whether or not a facility is ready for HIV/AIDS care and 
treatment. The tools were developed in a collaborative effort of representatives 
from the Ministry of Health/NACP and from several national and international 
partner organisation working with HIV/AIDS care and treatment programs in 
Tanzania (NACP 2005). 
During the first year (2004/2005) of the plan, 96 health facilities were selected to 
start with HIV/AIDS care and treatment. A care and treatment team of all these 
facilities received one week training on HIV/AIDS care and treatment. 
Assessment visits and re-assessment visits have been performed to 96 facilities 
in order to assess the quality of HIV/AIDS care and treatment services at the 
facilities. All the 96 facilities have received anti-retroviral drugs (NACP 2005). 
In the second year (2005/06), another 104 health facilities have been targeted to 
start anti-retroviral therapy. 
Scope of Care and Treatment at the Care and Treatment Clinic (CTC) 
People suffering from HIV related illnesses, may attend a wide variety of services 
at different levels of the health care system in Tanzania. These services range 
from a public or private multipurpose clinic or health centre and a home based 
care program to antenatal clinics and the prevention of mother to child 
transmission of HIV program (PMTC). Furthermore there are Voluntary Testing 
and Counselling (VCT) sites, Tuberculosis (TB) or sexual transmitted infections 
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clinics (STI), a general outpatient department unit (OPD) or an impatient ward 
prepared for patients with HIV/AIDS (NACP 2005). 
2.4.1 ARV Treatment in Tanzania 
After a decade of slow progress in the treatment of HIV infection, the last few 
years have seen dramatic advances in the development of antiretroviral drugs 
(ARV). They have been defined as the main form of treatment (yet not a cure) for 
HIV/AIDS (WHO 2002). This now offers extended patient survival and improved 
quality of life. Various new medications (such as protease inhibitors (Pis) and 
non-nucleoside reverse transcriptase inhibitors (NNRTis), when combined with 
other older nucleoside reverse transcriptase inhibitors (NRTis), have the potential 
to reduce HIV replication by crippling enzymes that are crucial in the replication 
of HIV. When a patient with HIV starts taking these drugs, the concentration of 
the HIV viral load drops rapidly. It is estimated that within three to four months of 
treatment, an initial HIV concentration of 100,000 copies per millilitre of blood can 
be reduced to a level below that of detection allowed by current technology. 
However, on stopping ARV treatment, HIV replication resumes and the viral load 
rapidly reverts to what it was prior to treatment. The circulating virus starts to 
weaken the immune system as reflected by the progressive fall in the CD4 
lymphocytes count which increases the rate of occurrence of opportunistic 
infections. 
Theoretically, the multiple steps in replication of HIV provide opportunities for 
intervention. Therapeutic regimens may be directed at one or several of the 
following stages essential for viral replication. 
• Attachment of HIV to host cell 
• Reverse transcription of viral RNA to DNA 
• Integration of pro-viral DNA into host genome 
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• Expression of the viral gene after it has been integrated into host cell DNA 
including the process of transcription of more viral RNA and the translation 
of viral proteins 
• Processing and post-translational modification of protein products of the 
virus 
2.4.2 Types of Antiretroviral Drugs 
The existing antiretroviral drugs fall into three main categories 
1) Nucleoside reverse transcriptase inhibitors (NRTis): This class of drugs was 
the first group of drugs to be used and was the mainstay of antiretroviral therapy 
for the last 13 years of the AIDS epidemic. The primary mechanism of action of 
this class is inhibition of viral RNA-dependent DNA polymerase (reverse 
transcriptase) enzyme. 
2) Non-nucleoside reverse transcriptase inhibitors (NNRTis): Similar to NRTis, 
this class of drugs acts by disrupting the reverse transcription of viral RNA into 
DNA which is then incorporated in the cell's nucleus. However, unlike the NRTis, 
they are not directed incorporated into the viral DNA but instead inhibit replication 
directly by binding to the enzyme reverse transcriptase. The resistance to these 
drugs however, develops rapidly especially when used alone. 
3) Protease inhibitors (Pis): These drugs competitively inhibit the HIV protease 
enzyme whose activity is critical for the terminal maturation of infectious virions 
and this inhibition prevents the maturation of virions capable of infecting other 
cells. 
Currently, there are only two combinations of three drugs (regimens) that can be 
used sequentially and be effective in suppressing viral replication. These are 
often termed as 151 line and 2nd line regimens. When resistance to the second 
line regimen develops, theoretically the increased viral replication leads to a 
progressive loss in CD4 lymphocytes and eventual progression to AIDS and 
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ultimately death. However, patients are encouraged to remain on the regime in 
spite of failure as there is some evidence that the resistant virus is less fit than in 
the absence of ARV. WHO recommends that, if a patient needs to change from 
2nd line regimen, he or she should be referred to a specialist physician for 
individualized care (WHO 2003). 
ARV first line regimen: 
The drugs recommended by (WHO, 2004) for a first line regimen in adults and 
adolescents include one of the four possible combinations listed below. 
d4T (stavudine) +3TC (Lamivudine) +NVP (Nevirapine) 
ZDV (Zidovudine) +3TC (Lamivudine) +NVP (Nevirapine) 
d4T (stavudine) + 3TC (Lamivudine) + EFZ (Efavirenz) 
ZDV (zidovudine) +3TC (Lamivudine) +EFZ (Efavirenz) 
ARV second line regimen 
The second line regimen recommended by WHO (WHO 2004) for adults and 
adolescents includes the following drug combinations: 
1) Abacavir 300 mg twice daily/ lopinavir I ritonavir 133.3/33.3mg (Katera) 3 
tablets twice a day and didanosine 200mg two tablets a day on an empty 
stomach 
2) Abacavir 300mg twice daily/ saquinavir/ritonavir (SQV 5X 200 mg or 1 00 mg 
bd plus RTV one mg cap bd) and didanosine 20mg two tablets a day. 
Monitoring patients on ARV therapy in Tanzania 
In Tanzania, according to the NACP (NACP 2005), CD4+ T-lymphocyte count is 
the gold standard method used to determine the time for initiation and change of 
therapy. Each patient should have a baseline CD+ T-lymphocyte count (and viral 
load where possible) done before initiating treatment. CD+ T-lymphocyte count 
should then be repeated at least every 6 months. It was found that, initial 
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immunological and virological response as reflected by CD4 count and viral load, 
were the most important factors in prediction of progression to AIDS or death 
over subsequent years. In patients with HIV-1 who are starting Highly Active 
Antiretroviral therapy (HAART), prognosis is strongly associated with CD4 cell 
count at baseline. High levels of HIV replication at baseline, older age, a history 
of AIDS and infection through injection drug use are also associated with 
increased rates of clinical progression (Egger 2003). Patients' characteristics at 
the time they start HAART, can thus be used to predict their probability of 
disease free-survival, and overall survival. Treatment in most cases be 
associated with weight gain and reduced morbidity from opportunistic infections, 
or lack of weight gain, may indicate treatment failure and so the need to consider 
changing regimens. 
Treatment is to be considered successful if the viral load decreases by 1 to 2 
logs (1 0 to1 00 folds) from the baseline level. However in most cases, CD4+ will 
be used instead of viral load thus a rise in CD+ T-lymphocyte count will indicate 
success. Treatment failure on the other hand is indicated by a viral load increase 
of 0.3 to 0.5 logs or a 30% fall in CD4+ T-lymphocyte count. 
2.4.3 WHO recommendations on ARV treatment 
Treating AIDS in the developing world means working in a context of poor health 
care infrastructure and limited financial and human resources, most of which are 
concentrated in capital cities. Health care providers in the developing world are 
faced with patients who have different characteristics to those seen in clinics in 
western countries: half of all cases in developing countries are among women of 
child bearing age: there are much higher of proportions of children affected; 
patients tend to be more in critical conditions as they are diagnosed late in the 
course of the disease; and they are commonly afflicted with one or more complex 
co morbidities, such as tuberculosis and malnutrition (Calmy et al. 2004). 
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The WHO recommends that before the treatment starts in a resource-limited 
setting, the following should be taken into consideration: documentation of past 
medical history, identification of current and past HIV-related illnesses, 
identification of other medical conditions that might influence the timing and 
choice of ART and current symptoms and physical signs of other medical 
conditions such as TB and pregnancy (Avert 2005). This assessment will help to 
identify the stage of H IV disease the person has. 
According to the WHO, all HIV patients having WHO stage IV disease, should 
start treatment. However, the decision on whether other people should start 
depends also on the laboratory tests that are available especially the person's 
CD4 cell count. A CD4 test measures the number of CD4 or T-helper cells in a 
patient's blood. The more CD4 cells in blood, the stronger is the immune system, 
and the better the body can fight illnesses (WHO 2003). WHO recommends that 
a person should start treatment when one is in WHO stage IV disease regardless 
of CD4 count, WHO stage Ill disease taking into account if the person has a CD4 
count less than 350 and WHO stage I and II disease with a CD4 count less than 
200 (WHO 2003). 
The increase in the affordability of, and financing for, ARV has resulted in a rapid 
expansion of programmes providing ARV and of countries planning to introduce 
or scale-up access to ART (Picazo 2003). Whilst global organizations, such as 
the WHO and the International Human Immunodeficiency Virus (HIV) Treatment 
Access Coalition are supporting country efforts to increase access to treatment 
through a series of regional consultations exploring opportunities for scale-up 
and lessons learned from pilot initiatives (Kapp 2002), there is a lack of clear 
evidence-based information to guide policy makers and planners in resource-
poor countries. 
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CHAPTER THREE: LITERATURE REVIEW 
3.1 Overview 
This chapter provides a review of the studies on the extent of HIV/AIDS 
pandemics in Africa, the socioeconomic status of individuals with HIV and their 
utilisation of public facilities. It includes affordability and sustainability of 
antiretroviral drugs in the context of limited resource settings. The related 
international research and the methodological approaches will be discussed. 
Finally, equity concepts regarding the distribution of ARV will be explored. 
3.2. Introduction 
HIV/AIDS is considered one of the most threatening diseases in the world today 
(WHO 2004). Life expectancy and child survival rates have declined 
tremendously in some of the worst affected countries and the disease is today 
having a major impact on social and economic development not only in health 
but also in education, agriculture, transport, industry, human resources and the 
economy in general. Sub-Saharan Africa is one of the regions that has been hit 
hardest by the HIV/AIDS epidemic. In this region alone, about 29.4 million people 
were estimated to be living with HIV in 2004 with approximately 3.1 million new 
infections having been anticipated to have occurred ( UNAIDS,2004). 
In Sub-Saharan Africa, the national HIV prevalence rates vary greatly between 
individual countries. There is empirical evidence that in some African countries, 
the epidemic is still growing while others face an increasing danger of explosive 
growth. In Cameroon, for example, there was a sharp rise in HIV prevalence 
(more than doubling to over 11 %) between 1998 and 2000. In Somalia and 
Gambia, the prevalence is estimated to be fewer than 2% of the adult population 
while in South Africa and Zambia around 20% of the adult population is infected 
(Avert 2004). However, in some of the Southern African countries, the national 
HIV prevalence rates for the adult population exceed the rates for South Africa 
and Zambia e.g. Botswana (37.3%), Swaziland (38.8%), Lesotho (28.9%) and 
Zimbabwe (24.6%) (Avert 2004). 
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In West and Central Africa, the infection rate is still relatively low although in 
some countries the prevalence rates are creeping up. The HIV prevalence rate 
is estimated to exceed 5% in a number of countries including Cameroon (6.9%), 
Central African Republic (13.5%), Cote d'lvoire (7.0%} and Nigeria (5.4%) (Avert 
2004). On the other hand, HIV infection in East Africa varies between adult 
prevalence rates of 2.7% in Eritrea to 8.8% in Tanzania. In Uganda the 
countrywide prevalence among the adult population has declined from 9% and is 
estimated at 4.1 %(Avert 2004). 
3.3 Socioeconomic status in relation to HIV/AIDS and ARV treatment 
It is believed that poverty and illiteracy raise the probability of HIV infection. This 
is possibly due to the fact that people with low income and little education are 
less able to afford condoms and may also have less access to information about 
dangers of high-risk behavior (Cowan et al. 1994; Krueger et al. 1990; McCoy et 
al. 1996). However, at least in the first decade of the HIV/AIDS epidemic in 
Africa, HIV infection did not follow this pattern (Ainsworth and Semali 1998). 
Pilot studies have demonstrated the clinical feasibility and effectiveness of highly 
active antiretroviral therapy (HAART) in a range of resource-poor settings, 
including Cameroon, Cote d'lvoire, India, Kenya, Malawi, Senegal, South Africa 
and Uganda (Attawell and Mundy 2003). Patients have demonstrated good 
adherence, and there is limited evidence of the development of resistance 
(Attawell and Mundy 2003). Mascoloni (2002), in an article presented at the 
Barcelona AIDS Conference, identified factors contributing to effectiveness as 
careful preparation and counseling of patients prior to starting treatment, training 
family members to support patients, local government and community support, 
and recovery from AIDS illnesses, which strengthens patient commitment. 
Antiretroviral drugs for HIV positive patients have been found to be effective in 
prolonging the lives of HIV patients and reducing incidence rates of opportunistic 
diseases such as Tuberculosis (TB} (Forsythe 2002). Studies conducted about 
the effects of ARVin New York and France found that associated health benefits 
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included a 41% drop in hospitalization, 41% drop in new AIDS cases and a 69% 
reduction in death from AIDS (Forsythe 2002). 
Studies have shown that ART reduces the risk of tuberculosis (TB) by as much 
as 80 percent. For example, in Brazil, TB incidence of 8.4 per cent was reduced 
by 80 percent in patients with CD4 counts below 200. In South Africa, TB 
incidence was reduced from 17 per cent to 3 per cent in a group of patients with 
CD4 counts below 200 (WHO 2004). However, evidence from countries including 
Thailand, Botswana and South Africa, shows that HAART alone will not prevent a 
rise in TB cases among people with HIV. For example, in Botswana, a 
combination of HAART with a well-managed DOTS programme that has 
achieved 90 percent treatment completion rates, TB remains the leading cause 
of death among people with HIV (Attawell and Mundy 2003). 
Developing countries, including Tanzania, are facing challenges of ensuring 
equitable access of antiretroviral treatment to people living with HIV/AIDS. Where 
the need and demand for ART exceeds the current ability to deliver, some people 
will receive treatment and others will die. Such a situation poses serious ethical 
issues for governments, international agencies, non-governmental organisations 
(NGOs), health care institutions and workers (WHO 2004). 
According to WHO (2004), with some exceptions such as Brazil, where ARV is 
provided at no cost within the public health sector, "ability to pay" is determining 
access to drugs in many low and middle-income countries. The drugs 
themselves may be obtained privately and medical care as well as related 
services such as laboratory monitoring is often provided through the private 
sector. The public/private distinction is however blurred by the fact that private 
patients who can pay for the drugs are often treated and monitored in "centers of 
excellence" (e.g. the teaching hospitals of major cities) which themselves are 
publicly funded. 
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A few patients in developing countries receive drugs at subsidized cost through 
donor supported projects such as the UNAIDS Drug Access Initiative in Ivory 
Coast. Similarly, in Senegal, less than one hundred patients are being treated 
with antiretroviral drugs, through an initiative supported by the National Aids 
Control Programme, Agence Nationale de Recherche sur le SIDA - France, 
lnstitut de Medecine et d'Epidemiologie Africaine- Paris and Fondation d'Espoir-
France. However, Attawel and Mundy (2003) found that even with subsidized 
cost, treatment may not be affordable for the poorest. Experience outside of 
large-scale national programs indicates that the poor are the least likely to 
access anti-retroviral therapy (ART). For example, in the Drug Access Initiative 
(DAI) in Cote d'lvoire, despite efforts to ensure equitable access, poorer people 
were less likely to access treatment than those who were better off (Attawell and 
Mundy, 2003). 
A minority of people living with HIV/AIDS (PLHA) receive free treatment through 
participation in clinical trials which may be externally and/or nationally funded. 
This is the case in Thailand, where patients are receiving drugs through the HIV-
NAT clinical trials conducted in 19 hospitals around the country (WHO 2004). 
The proportion of people with symptomatic HIV infection who are receiving ART 
ranges from small to insignificant. It is estimated that, less than 8% of people 
who require antiretroviral (ARV) treatment can access these medicines in 
developing countries. For example, in Uganda, probably less than 1% of people 
with HIV related illnesses are receiving ART. In Thailand, nearly 10% of people 
eligible for treatment were being treated through the Ministry of Public Health 
(MOPH) programme in 58 hospitals, but that proportion has substantially 
decreased since then. In Brazil, however, nearly 100,000 out of 530,000 people 
with H IV infection are receiving ART following a presidential decree, in November 
1996, that access to antiretroviral drugs be made universally available through 
the public health system (UNAIDS 2004). 
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The high price of many of the HIV-related medicines and diagnostics offered by 
common suppliers - especially antiretroviral medicines - is one of the main 
barriers to their availability in developing countries. There are several other 
important barriers, including a lack of the basic components required for care, 
treatment and support of people living with HIV/AIDS, such as trained staff in 
health facilities, constant availability of laboratory equipment and supplies, 
sufficient funding, efficient pharmaceutical services, strong political will and 
government commitment. Wider availability of information on prices and reliable 
sources of medicines improves decision making processes in the context of 
procurement (UNAIDS 2004). 
Various countries, organisations, researchers and practitioners are proposing 
various criteria for ensuring equity in access to ARV in resource limited settings. 
Loewenson and McCoy (2004) indicate that explicit patient selection criteria or 
the involvement of communities in decisions about selecting patients can 
enhance equity and prevent the development of patronage or corrupt practices 
around treatment. 
3.4 Limitations on greater access of ARV in limited resource settings 
Antiretroviral drugs (ARV) started to be used in western countries with the launch 
of zidovudine in 1987 while highly active antiretroviral therapy (HAART) has been 
in widespread use in these countries since 1996. In developing countries, the 
widespread treatment of ARVs became a realistic goal in early 2001, when 
companies producing generic drugs reduced the price of treatment by 
announcing they could provide triple therapy at an annual cost of US$ 300 
(Calmy et al. 2004). However, it was clear that it would not be possible to 
replicate the western approach if large numbers of patients were to be reached 
due to the limited human resources, limited availability of drugs and lack of 
access to monitoring tools. Through practical experience and operational 
research, Medicins Sans Frontieres (MSF) and ministry of health partners have 
been moving towards a rationalization of available resources and simplification of 
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strategies. This process has focused on patient entry criteria, choice of therapy, 
drug supply management and delivery of care. 
With respect to antiretroviral therapy (ART) in lower income countries, the ART-
LING Study Group (2005) observed that only 39% of the participating clinics were 
publicly funded, indicating that the private health sector, profit-oriented or not, 
plays an important role in the delivery of HAART in lower income countries. 
Determined to find out the long-term sustainability of these treatment 
programmes the authors found that among the centers charging patients for 
care, the median cost per year of treatment represented a substantial proportion 
of the per capita income in low-income countries. The baseline data also 
indicated important differences between patients with and without follow-up 
information, and with and without baseline CD4 count, in terms of the type of 
clinic accessed (public or private) and the socio-demographic and clinical 
characteristics of the patients. 
In moving towards providing sustainable access to treatment for the majority in 
the developing world, Calmy et al. (2004) suggested that models of care must be 
adapted to the realities of these regions. Current treatment models have been 
developed in Europe and North America, and are based on the availability of 
more than 20 ARV drugs, decentralization of treatment, the routine use of 
sophisticated laboratory tools by specialists, and tackling of viral strains that 
predominate in wealthy countries (Calmy et al. 2004). In the context of the 
developing world, the simplification and decentralization of treatment are crucial 
for successful strategy to extend ARV therapy, facilitating adherence and 
optimizing the chances of sustainability and long term success. This includes the 
whole process of providing ARV drugs, inclusion criteria, management of side 
effects, choice of a drug regimen (first or second line), when to start therapy etc. 
In developed countries, simplification of the drugs is the most crucial component 
in ARV therapy (Cal my et al. 2004). 
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Apart from the complex ethical dilemmas, equity issues have to be taken into 
consideration in order to achieve fairness in health care financing. In addition, 
some other practical constraints in setting inclusion criteria in resource-poor 
settings have been identified. For example, access to free public health care 
through health insurance schemes that could help in paying the cost involved in 
accessing health care services is not common in developing countries and 
therefore, the cost for accessing health care is significantly out of pocket. In this 
case, the best solution is to offer free access to ARV drugs by prioritizing the 
medical criteria rather than ability to pay i.e. putting those with greatest risk of 
death (people living with HIV/AIDS) would greatly promote the notion of fairness. 
Another constraint that Calmy et al. (2004) observed was that the laboratory tests 
that are routinely used before putting patients on HIV/AIDS treatment in wealthy 
countries are inaccessible to most people in developing countries. Until 
accessible and affordable means of measuring CD4 cell count (or proxies such 
as total lymphocyte count) and viral load become widely available, the decision to 
start treatment must rely on clinical staging, which means prioritizing 
symptomatic (WHO stages Ill and IV) patients. Other than the doctors, this task 
can be done by clinical officers and nurses provided that they are sufficiently 
trained. 
In order to achieve good adherence, the affordability of ARV drugs by ensuring 
that treatment is provided at lowest cost as possible is very important. However, 
the continued political pressure to block the use of patented medicines threatens 
to stifle progress in making simple and affordable treatments more widely 
available (Calmy et al. 2004). The simplicity of fixed-dose triple combinations 
makes them attractive for both developed and developing world settings, but 
patent holders are unwilling to cooperate in producing these combinations, and 
they are only available through generic producers to developing countries. 
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Another constraint is assessing clinical treatment failure timely. This is also 
critical because waiting for clinical failure before changing drugs allows increase 
in viral load and decrease in CD4 count, hence the higher failure rates. 
Therefore, a simple and inexpensive rapid test to detect early virological failure 
and to optimize the alternative therapy is also needed. Also, it is important to 
monitor toxicity and support diagnosis of opportunistic infections. For example, it 
is difficult to diagnose tuberculosis depending on the number of specimens 
examined i.e. Ziehi-Nielsen detects 30-60% of the culture-positive tuberculosis 
suspects (Calmy et al. 2004). Moreover, as the degree of immunosuppression 
increases, the frequency of extrapulmonary tuberculosis and mycobacteriaemia 
also increases, leading to difficult diagnostic challenges in places where culture 
and biopsy are not readily available (Calmy et al. 2004). In pediatrics, there is 
also no easy means of diagnosing tuberculosis in HIV-positive children so the 
clinicians have to rely on a combination of clinical score and radiography to 
diagnose pulmonary tuberculosis. 
With regard to the high prevalence of tuberculosis among HIV infected people, 
there is a need to integrate ARV treatment within tuberculosis treatment 
programmes. For example in Malawi, Calmy et al. (2004) found that the 
tuberculosis programmes are mostly decentralized while ARV treatment initiation 
and follow-up is often still very centralized, resulting in relatively low uptakes for 
ARV treatment among HIV-positive patients with tuberculosis (WHO stage Ill or 
IV). It was also found that most patients with tuberculosis who are also HIV 
positive are too weak and cannot afford to return for additional consultations for 
ARV treatment initiation and follow-up while taking tuberculosis treatment. 
Therefore, there is a need for new models where ARV treatment and follow-up is 
integrated into tuberculosis programmes and gradually decentralized. Calmy et 
al. (2004) suggests that, in order for the ART scale-up to be successful, 
treatment programmes must be decentralized from urban centers to the 
community primary health-care setting. Patients cannot be expected to travel 
tens of kilometers every month to receive life-long treatment, and ARV drugs 
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have to be delivered as close as possible to where people live in order to ensure 
good adherence. Even in resource-poor and understaffed settings, this could be 
implemented at least for the follow-up of stable patients who have initiated ARV 
treatment in clinics. However, a critical barrier to scaling-up is lack of human 
resources. This is because most resources are focused in the cities, leaving the 
great responsibility to the less qualified medical staff in rural areas. 
A study by Kabugo et al. (2002) showed that the fee-for-service HIV clinic 
providing ARV treatment had successfully operated and managed patients living 
with HIV/AIDS. Those who survived and remained on therapy derived long-term 
virologic and immunologic responses to ARV drugs in a manner similar to those 
observed in industrialized countries. Therefore, strategies to reduce the financial 
burden and other barriers to uninterrupted care as well as incentives to increase 
such practice models should be further explored in the African context. 
3.5 Related international research on ARV provision 
There have been some efforts made by policy makers in some developing 
countries to set criteria that will sound more ethical in prioritizing the vulnerable 
and the least disadvantaged groups regarding equal access to ARVs. For 
example, a pilot study in Senegal was used to set criteria to offer ARVs. The first 
criterion was patient's residency followed by clinical status based on biomedical 
data. The patients in the study were assessed on the set criteria and if the patient 
passed the first two criteria, a third criterion of social profile was used. The social 
profile was aimed at assessing patient's capacity to adhere to treatment and 
ability to pay for ARVs (Bennett and Chanfreau 2005). 
In Uganda, a national policy for ARV expansion was developed in 2003 which 
among other issues defines criteria to determine who should receive treatment 
and a hierarchical system is used to determine eligibility. The first two criteria are 





either a priority or an ordinary group. Priority eligibility is granted to patients who 
require treatment immediately while ordinary eligibility is granted to patients who 
will receive ARV in the future. Patients in the priority eligibility group include 
pregnant women who are HIV positive and these are considered under the 
Prevention of Mother to Child Transmission programme (PMTCT), post exposure 
prophylaxis for health workers and rape victims, children, HIV/AIDS activists and 
participants in research projects already on ARV. These criteria are prevention-
driven and some reflect the social and economic benefit which may be derived 
from a certain group (Benett and Chanfreau 2005). 
In Mexico, after the introduction of free ARV, the first priority was given to 
patients who were already on treatment and those who met explicitly clinical 
criteria. A waiting list was also created for each state depending on the stage and 
severity of the disease (Bennett and Chanfreau 2005). Clinical related criteria 
take on an important role, whereby the gold standard is the CD4 count. 
However, this requires modern laboratory equipment. Unfortunately, many health 
care facilities in developing countries are not equipped with such testing 
equipment, and in most settings the application of these criteria is limited to 
urban areas. This may create room for inequities, as the relatively more wealthy 
dwellers in urban areas have better access to CD4 testing equipment as 
compared to their rural counterparts (Muula 2004). 
To eliminate inequities and to make the health system function effectively, it is 
essential to address the growing shortfall and maldistribution of personnel and 
resources in various regions. Jones (2004) proposes increasing the availability of 
health services, to improve financial, geographical and cultural accessibility of 
health services, and to improve the quality . 
A study on the socio-economic patterns of service uptake focusing on public 
sector programmes for voluntary counseling and testing (VCT) in South Africa 
showed that the two upper wealth quintiles were under represented while the 
second lowest was best represented (Thiede et al. 2005). In specific terms, the 
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low-income groups of people accessed more of the general services and utilised 
VCT at public sector facilities than the well off. The overall findings showed that 
socioeconomic groups were not evenly represented in clinic attendance and 
more especially exaggerated when it came to undergoing VCT. The least well-off 
quintiles among the townships' population appeared to take up the services more 
than the others as a result of various issues around the perceived quality of 
public sector services. This study made use of several household asset 
questions from the South African Demographic and Health Survey (DHS) in order 
to allow comparison with the DHS data set during the analysis phase of the 
study. 
3.6 Methodological approaches 
Several studies to examine the disparities in a particular health variable (e.g. 
usage of health services or health status) across people with different standards 
of living have been done. Even so, the question still remains on how best to 
measure living standards. Two approaches are prevalent in literature and these 
focuses on whether to use direct measures such as income, expenditure or 
consumption while the other one is concerned with the use of a proxy measure 
by making use of the best available data. Gwatkin et al. (2005) tried to make the 
distinctions between these approaches as follows. 
Income approach 
This approach is straightforward and appealing because respondents are asked 
a simple question along the lines of how much their household income in the past 
year was and the respondents are expected to place their estimated annual 
income in a bracket rather than report the exact amount. However, practical and 
conceptual issues arise. For example, the respondents may not respond 
truthfully, especially if they think their answers may leak back to the authorities. It 
is also not easy to be able to recall accurately all household members' incomes 
from all sources, for the past year. Questions concerning labour income and 
unearned income, including transfers, in-kind income such as gifts of food from 
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neighbours should be treated differently. It is also not clear whether income 
should be measured before or after taxes. If the expenses associated with 
running the family business are to be deducted from income to derive net income 
the emerging question is how to collect the data on such expenses. For example, 
it is not clear how expenses associated with a piece of equipment such as a 
tractor should be handled. 
The information collected to date on household income in developing countries is 
typically of poor quality, not least because of these problems. A study done by 
Gasparini and Panadeiros (2002) on assessment of changes in the distribution of 
benefits from health nutrition policies in Argentina provides an example of a 
useful income approach to measurement when neither expenditure nor 
consumption data are available. The authors utilise two large living standards 
surveys to obtain data on utilisation of targeted health and nutrition programs in 
Argentina. Although these surveys do not provide insight into expenditure, the 
authors estimated household welfare using household income and adjusting for 
household size applying an equivalence scale. Utilisation rates for the programs 
were then analyzed across the distribution of this adjusted income measure. 
However, conceptually it is not clear whether income is the best measure of living 
standards, because it merely captures how much money is coming into the 
household. As such, it may not give an accurate picture of the household's living 
standard. Taking the case of pensioners, for example, in the developing world 
pensions are likely to be small and people may subsidise their living standards by 
using up their own savings. 
Expenditure approach 
Under the expenditure approach, respondents are asked about household 
spending patterns which are aggregated to a spending figure. However, again 
some technical and conceptual issues arise. For example, it is not explicit 
whether it is sufficient to measure expenditure over a specific time period (week, 
month or year) or whether to concentrate on the type of purchase during a given 
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time period. In addition, it is not clear how "lumpy" purchases, such as a car or a 
television set, should be handled. 
In developing countries, the major problem with the expenditure approach is that 
many households grow a great deal of food for subsistence purposes which 
constitute a large fraction of their total consumption. As such, a household may 
look poor from an expenditure standpoint because it gets its food from its own 
plot and yet it may be actually enjoying a reasonable standard of living. Another 
problem is that subsidies may give a distorted picture of living standards. For 
example, one household may be able to live rent free because the head of the 
household is a doctor at the village clinic or a state-enterprise worker. Judged by 
expenditure, the household would appear poor because it pays no rent, but this 
would be the wrong inference. 
Consumption approach 
This approach has been used frequently by the World Bank, particularly in the 
context of Living Standards Measurement Studies (LSMS) (Deaton and Zaidi 
2002). A household's food consumption is defined as the sum of its own produce 
and any produce that it buys from others or is given by others. However, this 
approach also has certain problem regarding how to treat consumption. For 
example, if a household has a small business producing handicrafts and keeps 
some for its own use, these products are counted as consumption while the 
proceeds from the sale of the remaining products show up in the household's 
consumption of other items (for example, school uniforms bought from the 
proceeds). The consumption approach only measures expenditures on 
consumption goods and does not attribute these expenditures to the use value of 
each good. The use value of a good, however, depends on the purchase price 
as well as the expected life of the good. 
Further, the consumption approach does not look at the amount of rent a family 
pays for its accommodation but at the imputed rent-the amount it would have 
36 
had to pay had it rented its accommodations at the market rate. Everyone, 
whether living in a rent-free government house, personally built house, or a 
rented house, is assigned a positive imputed rent. However, the approach is 
complex and time consuming especially when if the assessment of living 
standards are not the main goal of the exercise. 
Due to the above and some other related shortcomings, large-scale household 
survey exercises such as the Demographic and Health Survey (DHS) have 
eschewed the consumption approach. In fact, the DHS, somewhat surprisingly, 
has eschewed all approaches to measuring living standards, leaving researchers 
in the frustrating position of having excellent household data on maternal and 
child health variables but no income, expenditure, or consumption data that 
would, for example, allow them to compare immunization rates among the poor 
with those among the better off. This situation led researchers to look at the non-
health information collected in the DHS and asked whether it could be used to 
construct an ad hoc proxy measure of living standards. The conclusion was to 
the affirmative (Filmer and Pritchett 2001 ). 
The asset index approach 
The asset index approach, deriving an index of household wealth based on 
household assets with the help of principal component analysis (PCA), is often 
used to measure living standards. Some of the studies utilise actual DHS data to 
which the asset index approach is applied, while others compute living standards 
measured by applying the asset index approach to data sets other than those 
produced by the DHS. One such study that used DHS information was 
conducted by Thiede et al. (2005) who explored the use of voluntary HIV/AIDS 
counseling and testing in South Africa. Another study was conducted in Kenya 
by Montagu et al. (2005) who looked at the use of reproductive health services 
through the private sector in Kenya. 
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A study done by Barros et al. (2005) focused on the question whether health and 
nutrition programs are reaching the neediest used a non-DHS data set. The 
inequality was measured by applying PCA to both the Brazil DHS and data from 
regional surveys to construct an asset measure. In addition, a study done by 
Schwartz and Shushan (2005) assessed the effectiveness of contracting out 
primary health care delivery by constructing a household wealth index using PCA 
that was applied to baseline and follow-up surveys in Cambodia. The other 
example is a study on reproductive health among Nepalese adolescents where 
the asset index approach was applied to baseline and end line surveys of urban 
and rural communities where a targeted, community-based, participatory health 
programme had been initiated for disadvantaged youths. The resulting asset 
measures were used to assess inequalities in the effectiveness of the youth 
programmes. Peters et al. (2005) also utilised the PCA-based asset index 
approach to construct a socioeconomic status indicator from a family health 
survey in Uttar Pradesh State, India. Yet another application of the asset index 
approach was done by Anwar et al. (2005). In this instance, the PCA was 
applied to the 1996 census data collected from a rural area of the Ganges-
Meghna Delta in Bangladesh. 
Given the diversity of data and research questions addressed above, the PCA 
approach to living standards measurement appears to be reliable. This approach 
to living standard measurements, in contrast to the income, expenditure, and 
consumption approaches, does not produce a cardinal measure of living 
standards, let alone a monetary one. However, this approach cannot be used to 
determine whether people are poor in the sense that they live on less than a 
given monetary poverty threshold. In addition, it is not possible to make 
comparisons across countries because it is incorrect to say that a household with 
a score of --o. 75 living in Tanzania is poorer than one with a score of --0.25 living 
in Botswana. The PCA only makes it possible to rank households within a 
specific context, and we can say that within a specific sample a household with a 
score of -0.75 is poorer, according to this measure than one with a score of 
-0.25. 
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From the point of view of capturing inequalities between poor and less-poor 
people, the approach seems to work reasonably well because the program 
administrators could organize an exit survey of users and ask them about their 
dwelling type, their ownership of household durables, the water supply they use, 
and so on. Armed with these data, the administrator could apply the PCA weights 
from a national survey (for example, the country's DHS) and generate for each 
user of the program's facilities a score on a proxy wealth index. From the national 
survey, the administrator will know the cut-off points on the wealth index that 
separate the poorest quintile from the second poorest, the second poorest from 
the middle quintile, and so on. 
3.7 Related international research using asset indices 
A number of studies have been undertaken to investigate whether publicly 
funded programs reach the poor people. These studies are relevant to my study 
since they also used PCA to establish the socioeconomic status of people 
accessing health services in a particular country. Filmer and Pritchett (2001) 
conducted a study to estimate the relationship between household wealth and 
children's enrollment in India. They used a proxy indicator of wealth by 
constructing a linear index from asset ownership indicators using PCA to derive 
the weights. To validate the method and to show that the asset index predicts 
enrollments as accurately as expenditures or more so, they went further by using 
the data set from Indonesia, Pakistan and Nepal that contain information on both 
expenditures and assets. The results showed large, variable wealth gaps in 
children's enrollment across Indian states. 
Another study done by Grabowsky et al. (2005) was done in Ghana and Zambia 
on achieving equity in the distribution of insecticide treated bed nets (ITNs) 
through links with the measles vaccination campaign. The wealth index was 
measured by asking the head of households' questions on household assets. A 
scoring system was drawn from the DHS as developed and reported by the 
World Bank (Gwatkin et al. 2000). The scores were summed by household and 
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individuals were ranked according to the total score of the household in which 
they resided. The sample was then divided into population quintiles i.e. five 
groups with approximately the same number of individuals in each. The study 
found a substantial increase in the ratio of ITN ownership between the poorest 
households compared with the least poor. Although the study was looking at ITN 
provision, it is very relevant to our study because of the similarity in methods 
used to identify the poor people accessing health services. 
In Tanzania, a study done by Schellenberg et al. (2003) on health care for 
children in rural southern Tanzania showed that care seeking behaviour was 
worse in poorer than in relatively rich families even within a rural society that 
might be easily assumed to be uniformly poor. A baseline household survey was 
undertaken, focusing specifically on the extent to which care's knowledge of 
illness, care-seeking outside the home, and care in health facilities were 
consistent with Integrated Management Of Childhood Illness (IMCI) guidelines 
and messages. They used PCA to develop a relative index of household socio-
economic status, with weighted scores of information on income sources, 
education of the household head and household assets. 
In conclusion, there is no single ideal approach. Some studies are using benefit 
incidence analysis (BIA) to calculate the benefits associated with the program 
and see how they are distributed across the population, paying particular 
attention to the distribution between the poor and the better off. Benefits, usually 
expressed in monetary terms, are based on records of service utilisation. For 
example, if the programme in question is the government's entire spending 
program for the health sector, the study would ask how many primary care visits, 
how many hospital outpatient visits, and how many hospital inpatient days each 
individual or household had in the period covered by the study. Each of these 
would then be converted to a monetary amount by multiplying the number of 
visits or days by the amount of government spending or subsidy involved. This 
may vary from one individual to the next-for example, from the poor to the rich. 
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As shown above, majority of publicly funded programmes discussed showed 
successful efforts at reaching the poor. However, none of the studies focus on 
the socioeconomic status of patients receiving ARV in the public facilities i.e. 
whether these services are reaching poor people infected with HIV. This study 
aims at filling this gap. 
3.8 Equity Principles 
In this section, several ethical principles and equity principles that can potentially 
be applied to guide decisions in choosing scheme for fair ARV provisions will be 
discussed. This will provide an overview of criteria decision makers can apply in 
a particular country to set priorities for the provision of free ARV with regard to 
the eligibility of different socio-economic groups. 
Equity is a broad concept that is related in some way to the idea of a fair 
distribution of something or the other across different individuals and groups in 
society (Mooney 1983). It is important to distinguish between equity and equality 
within concepts of a fair distribution. Equity is about fairness, and it may be 
judged fair to be unequal in some instances. For example, in health care it may 
be judged equitable to have unequal access to services in a sense that groups 
who are more likely to be ill (elderly people, children under five years and 
pregnant women) should perhaps be given greater access to health care 
services than those who are less likely to be ill because the chance that they 
might fall sick is higher as compared to young people. Thus, equity can only be 
achieved if resources are allocated in a fair or just way within each society (Van 
Doorslaer et al. 1993). However, it should be noted that fairness is a value 
judgment. This therefore implies that an equity goal adopted in one health 
system may not necessarily be the same in another health system. 
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Logically, equality of health cannot be achieved since there are many factors that 
influence the health of individuals including genetically inherited conditions, 
natural deterioration in health over time, age, gender and the individual's 
perception on their heath. Considering these factors, it is unlikely to have equal 
health for all. Donaldson and Gerard (1993) argue that attempting to achieve 
good health may be seen as elitist in the sense that informed individuals are 
prevented from choosing their own level of health which may be somewhere 
below "good health". For example, a person may choose not to give up smoking. 
Such a goal would bear negatively on the quality of life on a community. The 
objective for equity should be provision of opportunity, which is about health care 
rather than health itself. 
Equity can be viewed in two broad aspects: horizontal equity and vertical equity. 
Mooney (1983) defines horizontal equity as equal treatment of equals and 
vertical equity as unequal treatment for unequals. Therefore, horizontal equity 
means those with the same health conditions should get the same treatment in 
all aspects while in vertical equity means unequal treatment for unequal need. 
In terms of ARV treatment, horizontal equity could mean that those patients with 
a CD4 below a certain threshold be given the same equal opportunity to access 
similar health care. Also, individuals living in different geographical areas of the 
country should receive the same treatment regimes for the ART programmes and 
also use the same services equally. 
In terms of HIV/AIDS, the vertical equity principle means that patients who are in 
stage 1 of their disease would not necessarily be given the same measure of 
treatment and care as those ones in stage 4 of AIDS disease since they would 
have different symptoms of the disease. Also, in health care financing, If ART are 
funded by the government through taxation, then vertical equity principle would 
mean that, the rich should pay a high proportion of their income in order to cross-
subsidize the poor and that will reduce the burden to the government on 
providing the drugs to the poor. 
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However, dilemmas are still on how to assess equity among social groups (rural 
vs. urban, men vs. women, rich vs. poor). Evans et al. (2001) argue that in 
comparing men and women, one may question how to weigh the fact that women 
often tend to have longer life expectancy but higher morbidity as compared to 
men. This is because there are no standards or obvious criterion that explain this 
and even if the criterion exist, one could still argue that the norms of health that 
were developed for men do not apply to women (Evans et.al 2001) 
The following three particular theoretical concepts dealing with equity will be 
discussed in order to explain their useful as regard to equal utilisation of free 
ARVs provision in Tanzania. 
The utilitarian principle 
In general terms, the utilitarian principle calls for maximising the overall societal 
benefits. In terms of the health sector, the utilitarian principle means to maximize 
the overall health benefits of the society as a whole and thus to maximise the 
sum of individual well-being. Although the utilitarian principle has been 
understood to embrace considerations of justice, it does not provide a basis for 
choosing among the eligible groups in the most equitable manner. A common 
critique of utilitarianism is its inability to address issues of distributive justice 
(McGuire et al. 1988). Utilitarianism has a strong focus on efficiency, while equity 
is about a fair distribution of resources and not necessarily maximization of utility. 
In the context of ART, the strict application of utilitarian principles means to 
preferentially treat those patients whose health improvement would be greatest, 
i.e. whose medical conditions have greater chances of survival and the expected 
remaining life expectancy is greatest. Compelling to this principle, one might 
possibly argue that those with an advanced state of H IV would benefit less from 
ARV provision because giving priority to the sickest will reduce the chances of 
success of treatment. However, experience has shown that even severely sick 
patients can benefit from a significant increase in life expectancy. Again, this 
would oppose the equity principle that requires fair chance of treatment to 
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everyone regardless of the overall health outcome and could have implications 
for policy issues. 
The egalitarian principle 
According to the egalitarian principles of justice, the emphasis lies on the equality 
of outcomes. According to Evans et al. (2001 ), the egalitarian principle in health 
sector could mean equality in health outcome. Evans et al. (2001) argue that 
egalitarianism in the context of health requires that people be given an 
opportunity to have equal health status, hence the authors stress the equality of 
opportunities, which entail equal access to health care. However, justice in health 
may also be interpreted as the equality of health care resources. This would call 
for distributing resources equally among persons or distributing goods, such as 
health care services, equally among different groups. This does not 
automatically capture the existence of different health care needs. People 
suffering from TB or malaria in addition to HIV/AIDS have greater health needs 
than people living only with HIV/AIDS. Aiming at equalising health care would 
lead to a diversion of resources to interventions that produce very small benefits 
for people and inhibiting the people who require enormous resources to obtain 
any benefit at all (Macklin 2004). 
The maximin principle 
Under this principle, which is based on Rawls (1971 ), those who are worst off are 
given priority, i.e the maximum of good should be directed at those with minimal 
endowments. In the health care delivery context, this usually refers to those who 
are worst off in terms of health status. However, Macklin (2004) urges that the 
maximin principle could be also applicable to the most vulnerable e.g. orphans, 
marginalized or discriminated groups, poorest and sickest. In broad terms, it 
means that the highest priority should be given to the least economically 
advantaged individuals because they are more likely to have poor health status 
and yet can not afford to access health care services. With regard to the 
provision of ART, this implies that the least advantaged group and the sickest 
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(clinically advanced stage) should be prioritized regardless of how much they 
would benefit from ARV. However, the maximin principle conflicts with principle 
of utilitarianism because the interpretation would be to divert resources from 
those who could benefit more from the treatment. 
Access vs. utilisation 
Equal utilisation for equal need requires conditions whereby those who have an 
equal need for health care make equal use of health care (Oliver and Mossialos 
2004). Compared with equal access for equal need, equal utilisation may require 
more efforts by policy makers, and would require that potentially acceptable 
reasons for unequal use of healthcare services (by those in equal need) be 
overridden. These acceptable reasons should not be confused with unacceptable 
reasons for differential use of health care. For example, some individuals (or 
groups of individuals) may be better informed and more adept at accessing-and 
making full use of-health care than others. Differences in lifestyle preferences 
and/or levels of risk aversion may lead to differences in the utilisation of health 
care, but the principle of equal utilisation for equal need does not allow for these 
considerations (Oliver and Mossialos 2004). 
Equal access for equal need seems to be the most appropriate principle of equity 
for the healthcare policy maker to pursue, because (1) it is specific to health care 
and does not require that we discriminate between people who are already ill 
purely on the basis of factors that are exogenous to their health, and (2) it 
respects acceptable reasons for differentials in health care utilisation by those in 
equal need. 
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Need vs. utilisation 
According to Oliver and Mossialos (2005), need is defined along the following 
four dimensions (1) normative need, in which an expert, professional 
administrator, or scientist defines need by laying down their desired standard and 
comparing it with the standard that actually exists; (2) felt need, in which need is 
equated with want, and is assessed by simply asking a person or population if 
they feel they need a service; (3) expressed need, where felt need is turned into 
action; (4) comparative need, where the characteristics of a population who 
receive a service are ascertained, and where people with similar characteristics 
who do not receive the service are adjudged to be in need. 
Supply and Demand of Health Care 
In general, supply maybe seen as the only relevant consideration for securing 
equal access for equal need. However, it is also important to consider demand-
side aspects, such as the individual's ability to pay for health care. For example, 
in developing countries user charges are increasingly being used as a method of 
cost-sharing and to quell the demand for health care, but there is some evidence 
that user-charges have a negative impact on the demand for health care in lower 
income groups than in higher income groups. Assuming that the suppressed 
demand in the face of user-charges is for needed health care (and that access to 
health care is not currently favourably biased towards the poor), the increase in 
or introduction of general patient user-charges may well have a detrimental effect 
on the principle of equal access for equal need (Oliver and Mossialos 2004). 
Moreover, the geographical proximity to healthcare services varies quite 
considerably within many countries and there will always be some acceptable 
variations in the supply of health care services, especially specialist health care 
who cannot be allocated entirely equally across all areas. However, efforts have 
to be made to ensure that all areas/regions are equally serviced by the range and 
quality of health care specified by the policy maker. According to Oliver and 
Mossialos (2004), these efforts can be met by ensuring the following. Firstly, 
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healthcare resources must be distributed to regions according to population size, 
local input costs (for example, labour and capital), healthcare needs, and the 
income mix within each regional population, rather than any historical pattern of 
distribution towards relatively wealthy regions (subject to specific targeting of 
resources to supra-regional centers of excellence). As a consequence, the local 
purchaser and provider use of healthcare resources must be monitored to ensure 
that the resources are used in a manner that is consistent with promoting equal 
access for equal need. Secondly, efforts ought to be made to overcome any 
"inequitable" capacity constraints in "disadvantaged" areas, to ensure that there 
are incentives/directives for sufficient facilities and staff to locate and retain within 
these areas. 
On the demand side, there are some important factors such as knowledge, 
information, cultural beliefs, indirect financial costs (for example, travel costs), the 
opportunity cost of patients' time (for example, foregone wages), and their 
preferences that may contribute in equal access to health services. There is a 
need for more research to ascertain the relative extent to which any observed 
income related differentials in healthcare utilisation (and non-utilisation) are either 
the consequence of differential opportunities, or differential preferences. In 
addition, cultural factors may influence an individual's willingness to access 
health care across different groups in a particular community, (for example 
women may feel uncomfortable with the idea of visiting a male general 
practitioner). This issue may even be more relevant when considering groups 
defined by income, social class, etc. 
Since utilisation is easier to observe, most research on equity of access has so 
far used utilisation to approximate access to health services. However, as 
discussed earlier, the principle of equal utilisation for equal need does not 
account for acceptable variations in the use of health care, and consensus is 
required in defining the reasons for these acceptable variations. Moreover, there 
are some unacceptable reasons for variations in the use of healthcare use that 
have to be addressed both from the supply and demand sides. 
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Conclusion 
The above theories show that the strategies for equity in health care in a 
particular country depend on normative argument. It is unlikely to find only one 
proper theory of social justice prevailing in a particular country. 
In Tanzania, it is not clear which ethical and equity principle applies to the 
provision of ARVs in public facilities. There are some guidelines provided by 
Ministry of Health on the criteria used to provide ARV as discussed earlier, 
however, there are no clear indications on whether provision of free ARV is 
equitable or not. This study aims at filling this gap. 
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CHAPTER FOUR: RESEARCH METHODOLOGY 
4.0 Overview 
This chapter provides a detailed description of the methodology used in this 
study to collect both quantitative and qualitative data. The sources of data and 
the analysis of data obtained will be described. The chapter will also explain the 
methods used to evaluate information on the socio-economic status of those 
receiving free ARV in relation to the socio-economic indicators from the 1999 
Tanzania Demographic Health Survey (TDHS 1999). Particularly, principal 
components analysis (PCA) as an approach of choice will be discussed. Lastly, 
the limitations of the study will be highlighted. 
4.1 The Tanzania Demographic Health Survey (TDHS 1999) 
The Tanzania Demographic Health Survey (TDHS 1999) was undertaken in 
November 1999 and it was the fourth in a series of national sample surveys. The 
first was the 1991-1992 TDHS, which was followed by the Tanzania Knowledge, 
Attitude and Practices Survey (KAP) in 1994 and then by the 1996 TDHS. 
The primary objective of the 1999 TDHS was to collect data on at the national 
level (with breakdowns by the urban- rural and Mainland-Zanzibar residence 
wherever warranted) on fertility levels, nutritional status of young children, 
childhood mortality levels, knowledge and behavior regards HIV/AIDS, and the 
availability of specific health services within the community. Related objectives 
were to produce these results in a timely manner and to ensure that the data 
were disseminated to a wide audience of potential users in governmental and 
non-governmental organizations within and outside Tanzania. 
The ultimate intent was to use the information to evaluate current programs and 
to design new strategies for improving health and family planning services for the 
people of Tanzania. The survey was undertaken by the Tanzanian National 
Bureau of Statistics (NBS) in collaboration with other stakeholders. The 3,826 
households were selected for the sample, out of which only 3,677 were occupied. 
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Of the households found, 3615 were interviewed representing a response rate of 
98 percent. 
4.2 Study design 
A cross-sectional study was conducted to collect the data on the socio-economic 
status of HIV patients who access the antiretroviral therapy in selected ARV 
clinics in Tanzania. 
Cross-sectional data included socio-economic indicators and demographic 
characteristics of those patients receiving ARV. The information regarding the 
socioeconomic status of the patients receiving ARVs was obtained through a 
structured questionnaire administered to those patients that requested the 
Source of drinking water, availability of electricity, sanitation facilities, building 
materials of dwell ings, possession of valuable and durable goods. Also the 
following socio-economic variables were captured: Occupational history, 
employment, education and geographical location. To be comfortable and avoid 
noise, the interviews were administered in the waiting room of each facility. 
Information relating to knowledge, attitudes, practice of ARV, barriers to access 
ARV was obtained through focus group discussions composed mainly of 
community leaders, religious leaders, staff and other local community groups. 
The Information regarding the criteria and eligibility to be involved in the ART 
programmes was obtained from key informants (programme managers and 
heads of each ARV clinic visited). 
4.3 Study population 
The study population comprised all adult HIV patients accessing free ARV drugs 
in hospitals, primary health care facilities or in ARV clinics run by local NGOs in 
Tanzania. Because of limited resources, it was impossible to conduct the study 
across the entire population. The sample was taken from two regions, namely 
Dar es Salaam and Kagera. 
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It should be noted that the ARV programs in Tanzania are still in their infancy and 
hence the drugs are available mainly to the region and district hospitals. Hence 
only district hospitals from the selected regions were chosen for data collection 
i.e. Dar es Salaam urban district hospitals and Kagera rural district hospitals. The 
reasons for choosing these districts were as follows: 
• The study compares the rate of ART utilization between groups of different 
socio-economic status and contrasts the findings for a rural and an urban 
study setting. 
• Dar es Salaam is the commercial city of Tanzania. This means that the 
well established health care facilities are situated there, while Kagera is 
one of the fi rst regions in Tanzania to have an ART programme in the rural 
areas. 
• These regions can be considered to have rather well established ARV 
programmes that had been in place for the last one year at the time of the 
study. 
• Comparing to other regions providing ARVs, these regions were easily 
accessible within resource constraints. 
There were three health facilities selected from Dar es Salaam and other three 
facilities selected from Kagera, which are discussed in detail later. Therefore, the 
sample included patients from six facilities in total. 
Inclusion criteria: All adults with 18 years of age and above, receiving free ARVs. 
The patients should have been on these drugs not less than two months and had 
to be going only to these selected facilities to access the drugs. 
Exclusion criteria: All patients (less than 18 years), patients served by community 
based care and all patients with mental disorder. 
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It is estimated that about 400,000 patients in Tanzania require ARVs but only 
13,000 HIV patients access free ARVs. The sample size of 300 patients on 
ARVs was obtained randomly and then 150 patients per region were chosen. 
4.4 Sampling strategy 
By using the list of health facilities in Tanzania that offer ARV programmes, the 
following steps were taken: By using purposive sampling, two regions were 
purposively selected, one from rural and one from urban areas. Dar es Salaam 
was selected as the urban setting and Kagera was selected as the rural setting. 
By considering some of the criteria including well established programme, a 
sufficiently large number of patients attending the facility, easier accessibility to 
the facility and staff cooperation, these facilities within the regions were also 
purposively selected. Three different facilities were selected in Dar es Salaam 
and data were collected directly from these hospitals. In rural Kagera, one 
mission hospital and two public facilities were selected. Systematic random 
sampling in each facility of people waiting in the queue to receive ARVs was 
used in conducting the questionnaire interviews until the sample size was 
achieved. This means that, every fourth person waiting in the queue was 
approached and asked whether he/she would be willing to be interviewed. Focus 
group discussions were arranged on the basis of purposive sampling to select 
focus group representatives, while a snowballing method was used to identify the 
key informants. 
4.5 Data collection sites 
In Dares Salaam, the facilities selected were Mwananyamala Hospital , Amana 
Hospital , and Temeke Hospital. In Kagera, the facilities selected were Ndolage 
Designated District Hospital (DDH), Rubya Mission Hospital and Nyakahanga 
Hospital. All hospitals were well organized and ART programmes began in early 
2005. These ART programmes are funded by different donors through the 
Tanzanian Government. Although all the facilities mentioned above seem to be 
funded mainly by international organizations, some of the funds come from the 
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government line ministry- Ministry of Health under the Multi-country AIDS 
Programme in Africa (MAP). Data were collected from 241h November 2006 
through 21st December 2006. 
4.6 Data Collection instruments and methods 
Closed-ended questionnaires, focus group discussions (FGD) and key informant 
interviews were the research instruments. The socio-economic status of patients 
receiving free ARVs was captured through facility based questionnaires with 
closed-ended questions about gender, age, education, employment status, living 
conditions and household assets. Many of these questions were synchronized 
with the Tanzania Demographic and Health Survey (TDHS 1999). The questions 
allowed the comparison of the data set from questionnaires to that from the 
TDHS for the analysis of the study. Other questions concerning the knowledge, 
attitude, and practice around ARVs were also asked. 
A two days piloting study was conducted in order to pretest the tools that were to 
be used to make sure all questions were clear to interviewers and interviewees. 
This tool pre-testing study was conducted at two hospitals, namely Aghakan and 
Tumbi located in Dar es Salaam and Coastal regions respectively. Immediately 
after the piloting study, all necessary corrections including language, type of 
questions were made before the actual study began. 
Since the questionnaires were developed in English, the translation was made to 
Swahili (local language) because the majority of Tanzanians especially in rural 
areas can hardly communicate in English. However, it was again translated back 
to English to ensure the quality of translation. Two research assistants were 
employed to administer the questionnaires, and the main selection criterion was 
that they had to be university graduates with previous experience in data 
collection. There was a one-day training workshop for the research assistants to 
ensure the quality of the fieldwork. The training ensured that both research 
assistants understood ethical issues, the content of both the English and Swahili 
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questionnaire and also allowed for joint practice in order to develop skills for time 
management for administering the questionnaire. 
In-depth interviews with key informants and FGDs with community 
representatives were also conducted. Four key informant interviews with ARV 
programme managers (site managers) at the selected facilities were conducted. 
The reason for the FGDs was to establish the perception of ARV in the 
community and also to identify the barriers to access free ARV. The reason for 
in-depth interview with key informants was to evaluate the criteria considered for 
eligibility to access free ARVs in public facilities. 
The FGDs were divided into single sex groups. Five Males and five females were 
interviewed independently to avoid conformity because of the social interaction 
between males and females. Stewart and Shamdasani (1990) emphasise 
differences in ideas of males and females which in some contexts suggest 
gender separation in the context of FGDs. Five discussion groups were formed. 
Three FGDs were conducted in Dar es Salaam and two in Kagera. The FGDs 
comprised of six to nine people with common interests and experiences. The 
FGD and interview with key informants was only conducted by the principal 
investigator and the interview was tape recorded while research assistants 
helped to write filed notes. 
4.7 Ethical issues 
As discussed earlier, research assistants were trained to explain all the important 
issues before they began the interview. Issues to be explained were the purpose 
of the study, voluntary participation on the study and that the participant is free to 
withdraw from the study at any time they wish to and thus will not have any effect 
on their ARVs receiving. 
4. 7.1 Consent form 
A consent form was given to all interviewees and they had to sign it before the 
start of the interview. Participants were free to accept or refuse to sign it. 
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Participants were also told to ask any question whenever they wish to. The 
consent forms were in Swahili and there was not undue influence to the 
participants. 
4.7.2 Confidentiality 
Both quantitative and qualitative questionnaires were kept anonymous. Also 
there was no personal information collected, such as personal identity. All 
necessary information was kept by using a coding system. Efforts were made to 
ensure total confidentiality. During the research process, completed 
questionnaires were kept in a secure place, only accessible to the research 
team. The study had no harm, risks, pains or any other inconveniences to the 
subjects since it was the interview based study. 
Participants were told that all result findings obtained from the study will be 
disseminated to interested parties and stakeholders. Results/feedback will be 
distributed and discussed with relevant and interested bodies. These include 
representatives of relevant HIV organizations, policy makers in the Ministry of 
Health and other stakeholders. The results of the research will be made 
accessible to interested patients and the community through the facilities. 
4.8 Nature and Sources of Data 
• A total of 300 interviews were conducted, 155 from the Dar es Salaam 
region and 145 from Kagera. Data obtained from the questionnaires 
referred to the socio-economic status of those subjects receiving 
free/subsidized ARVs. 
• The Tanzanian DHS 1999 data on socio-economic status of the 
populations was used to compare with the socio-economic status of 
individuals obtained from the questionnaires. Access to the dataset was 
granted by Measure DHS. The TDHS 1999 was conducted by the 
Tanzania National Bureau of Statistics (NBS) and a total of 3615 
55 
households were surveyed. The TDHS was used as baseline data for the 
generation of an asset index and the establishment of socio-economic 
quintiles. 
• Through in-depth interview and focus group discussions, qualitative data 
were obtained. To ensure the quality of the data obtained, the interviews 
were recorded, transcribed and analyzed into codes and themes. 
4.9 Data analysis 
Data were entered manually from questionnaires into a master spreadsheet. 
Data were checked and cleaned by a system of double entries into twin 
spreadsheets for each questionnaire by separate members of the research team. 
After data entry completion these spreadsheets were compared and cross-
checked. The software packages used were EPI Info for data entry and STATA 
8.0 for data analysis. Focus Group Discussions were conducted by the principal 
investigator with the help of two research assistants. Key informant interviews 
and FGDs were tape recorded and field notes were written. 
4.9.1 Quality control 
The interview setting and conduct were synchronized to avoid any differing 
responses. Closed rooms were used to avoid noise and other inconveniences to 
ensure the privacy and confidentiality. 
Face validity was assessed by using a pilot study. 20 questionnaires were 
administered before the beginning of the main study. 
In case of any problems with the questionnaire, e.g. ambiguous questions, time 
length for one interview etc. were revised immediately after the pilot. 
Content validity was addressed through clarity of definition and terms. 
Reliability was accounted for by using the standardised questionnaire and 
interview guidelines, ensuring that tools in local language and English have the 
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same meaning. A one-day training workshop was also organized for all research 
assistants in order to ensure that the quality of the fieldwork was good. 
4.10 Constructing an asset index using principal component analysis 
An asset index was constructed in STATA 8.0 using principal component 
analysis. The asset index for individual i is defined as 
Where aik is the value of asset k for a household i, ak is the sample mean, sk is 
the sample standard deviation and fk is the score factor. 
Principal component analysis (PCA) is a popular approach used to construct an 
index of wealth from information on household ownership of durable goods and 
its housing characteristics. It seeks to describe the variation of a set of 
multivariate data in terms of set uncorrelated linear combinations of the original 
variables, where each consecutive linear combination is derived so as to explain 
as much as possible of the variation in the original data, while being uncorrelated 
with other linear combinations. The asset index is typically assumed to be the 
first principal component i.e. the first linear combination (more details on PCA are 
in the literature review section). 
The data from the Tanzania Demographic Health and Survey (TDHS 1999) was 
used for comparison. In order to permit a comparison with DHS data, the list of 
household assets and characteristics were chosen to get a close an overlap 
between the two surveys as possible. Asset variables within the questionnaire 
matched with the respective DHS variables. 
This approach made it possible to compare the socio-economic status of patients 
who access free or subsidized ARVs with the socio-economic status of the rest of 
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the population. The study population in both regions was divided into five socio-
economic quintiles. Weights were calculated for urban and rural data separately 
and TDHS households were allocated to separate quintiles for rural and urban. 
4.11 Limitations of the Study 
• The first concern is that the DHS data are relatively old and asset ownership 
patterns in Tanzania could have changed since we used the 1999 
Demographic Health Survey (TDHS 1999). 
• The second concern is that there were resource and time constraints as well 
as some bureaucratic hurdles put in place by various organisations that 
impacted on the fieldwork. Also due to some unavoidable circumstances, the 
FGDs in some facilities could not be interviewed separately. However, most 
of the bureaucratic at some facilities were sorted out that led to conduct five 
FGD comprising of both staff and patients. The idea was to interview them 
independently as these two different groups of people have power 
imbalances. This therefore could have introduced some sort of bias in the 
study because patients are not free to speak out their ideas and problems in 
fear that their treatment could be jeopardized. 
• The third concern is that the research relies on the answers from patients 
only, since the interviews were facility- and not household-based. This could 
have introduced some sort of bias in the study because the patient's assets 
ownership could be different from what the patient reported. Patients may not 
reveal their true asset ownership in order to avoid showing that they are not 
poor/ rich or vice versa depending on the circumstances. 
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CHAPTER FIVE: RESULTS 
5.0 Overview 
In this chapter the criteria considered by providers for eligibility to access free 
ARV treatment in Tanzania will be evaluated. The comparison of socioeconomic 
characteristics of people accessing ART to those of the overall population i.e. 
gender, age, education attainment, employment status, head of household in 
both rural and urban settings with respect to their utilisation rates will be 
established. In addition, knowledge, attitudes towards ARV and barriers to 
access free ARV among community members in both settings will be analysed. 
Finally, the socioeconomic status of people receiving ARV in terms of household 
asset possession will be described. 
5.1 Criteria considered by providers for eligibility to access free ARV in 
Tanzania 
The clinical condition of the patients and the level of CD4 count were the main 
criteria for eligibility. There are three classes of individuals who are clinically 
eligible to begin treatment and include; all those clinical criteria regardless of 
CD4+ cell count. Also the eligibility includes those patients that fall in WHO 
stage 3 with their CD4+ cell <350/mm and all who have a CD4+ count < 200 
cells/mm3 , regardless of their symptoms. Beyond clinical eligibility, it is important 
to assess and address the patient's willingness, readiness and ability to be on 
ART adherently. 
Psychological consideration (not exclusion criteria) therefore needs to be 
evaluated before initiation of therapy during several (three to six) pre-treatment 
visits i.e. the patient has attended three or more scheduled visits to an HIV clinic 
and concluded that there is no active alcohol or other substance abuse that could 
affect adherence and there is no untreated active depression. It is also strongly 
recommended that clients have disclosed their HIV status to at least one friend or 
family member who will become the adherence assistant and if possible should 
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join support groups. In addition, clients need to have accepted their HIV positive 
status, and have insight into consequences of HIV infection, the role of ART and 
the very real need to adhere strictly before commencing therapy. Finally, the 
patient has to able to attend the CTC on a regular basis (transport may need to 
be arranged for patients in rural areas or for those coming from remote site) or 
have access to services able to maintain the treatment chain. The following are 
some quotes from the key informants regarding the eligibility criteria. 
"Okay, the main thing we are looking at of course is WHO clinical stage 3 and 
4 and the level of CD4 count less than 200 as it is shown in this guideline. 
Those are the main criteria. But you see, again we don't want to force the 
patients to come for the treatment and that's why we have our counselors 
here as you may see that room. They counsel patients, advise on the role of 
ARV and their side effects and make sure they consent themselves or their 
close relatives before they start getting treatment." (Key informant from the 
National AIDS Control Programme (NACP)). 
"Here the social criterion is the fundamental thing we are looking at because it 
is crucial as far as adherence is concerned. So we make sure the patient has 
disclosed his/her HIV status to at least one of his member family or close 
friend so that the patient can get the support of course financially and morally. 
The financial support is important because so far the government has no any 
transport arrangements for the patients who can not afford to pay for the 
transport costs every time they come here." (Key informant from Kagera 
region) 
"You see, the important thing we are looking at here is the condition of the 
patients and level of CD4 count. So long as the CD4 count is below 200, 
immediately the patient will start drugs. We make sure the patient attend the 
VCT before starting drugs so that they know the importance and the effects of 
the drugs. So we follow what the guidelines say and there is nothing much I 
can tell you." (Medical Doctor from Dares Salaam region). 
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However, there are could be potential gaps between official and actual criteria 
as discussed above. For example, officially there maybe no discrimination on 
the basis of SES but in practice providers may ration drugs away from poorer 
patients if they perceive them to be less able to comply , or may ration them 
towards their friends and family. 
5.2 Socioeconomic characteristics of people receiving free ARV in 
Tanzania. 
The comparison between the socioeconomic characteristics of the people 
receiving free ARV to the overall population using TDHS 1999 was made and the 
following results were observed; 
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Figure 1 clearly shows that, in absolute terms, women utilise free ARV more 
(54%) than men (46%) in all facilities. When the data was stratified in rural and 
urban (as shown in Figure 2), it was found out that in urban areas women had 
higher utilisation (62%) of free ARV than men (38%). In rural areas men had 
higher utilisation (54%) of free ARV than women (46%). Three reasons can 
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explain these findings. Firstly, the data from the TDHS (1999) showed that there 
are more women than men, with women constituting 58% of the total population 
and men constituting 42%. However, it was found that the sex composition of 
the population does not show significant variation by urban-rural residence. 
Secondly, in urban Tanzania, women are more affected by HIV than men while in 
rural areas there are slightly differences of the rate of infections between men 
and women (NACP 2005). Thirdly, it is assumed that women are more sensitive 
to their health than men so that they can take care of their children so probably 
they respond more positively on the call for ARV than men. However, in rural 
areas, the majority of women are unemployed and decisions on their health care 
depend on their husbands. This could possibly explain the reason of relatively 
small percentage of women in rural areas utilising ARV. 
Figure 2: Provision of ARV by gender in rural and urban facilities 
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Level of Education 
Figure 3 shows the overall utilisation of free ARV according to patients' 
educational attainment. According to Figure 3, the majority of patients accessing 
ARV have primary level education (57.5%). Those with secondary level 
education (19.7%) had almost similar access compared to those who never 
attended school (20.1 %). Those with advanced and tertiary level education had 
the lowest level of utilization of ARV with only 1.3% each. The results were not 
surprising because there were some reasons explaining this trend. Firstly, the 
data from DHS (1999) shows that the majority of people in Tanzania (55%) have 
only primary education followed by non-education (32%), secondary education 
(11 %), advanced (0.4%) and those with tertiary education (0.1 %). Secondly, 
many studies in Tanzania have shown that the HIV pandemic affects individuals 
with no education or only primary education to a higher extent (MOH, 2005). 
Maybe this is because of lack of awareness of risky sexual behavior or because 
of limited access to condoms. Thirdly, all study sites were public facilities. 
People with higher education who tend to be economically better-off do not 
attend public facilities to the same extent and rather prefer private hospitals, 
where the perceived quality of healthcare services is higher and confidentiality 
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usually guaranteed. However, as compared to the DHS, it is obvious that the 
non-educated utilising ARV are underrepresented while those with secondary 
education and higher are slightly overrepresented. This could be also because of 
their differences on information and awareness of the existence of the drugs. 
The primary level refers to primary school education that takes seven years 
before entering secondary education. Secondary education takes four years and 
prepares a student to enter into advanced school. The advanced education takes 
two years and prepares a student to enter into university or other higher learning 
institutions (tertiary education). 
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Interestingly, the results are similar, even when the data are stratified into rural 
and urban facilities, as shown in Figure 4. However, those with no education in 
rural areas make up a higher percentage of ARV users than their urban 
counterparts. This could probably be due to the fact that there is a higher 
percentage of a non-educated person in rural areas than in urban areas. The 
opposite pattern is shown for those with secondary education and above, 
whereby urban individuals have a higher level of utilization of ARV than rural 
counterparts, which again could be due to the fact that a relatively small 
percentage of educated people lives in rural areas. The rural sub-sample did not 
capture a single person with advanced or tertiary education. The argument, 
however, can not be conclusive, as it was difficult to relate the findings to the 
prevalence of education levels in rural and urban areas due to lack of 
information. 
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Figure 5 shows ARV utilisation according to the age of patients. As it is shown, 
there was no big difference of age of patients receiving ARV even when the age 
was stratified into rural and urban. The age group between 30-40 years was 
utilising ARV more (40%) than other groups. This probably means that the most 
affected age group in both urban and rural settings was the 30-40 age groups. 
The findings by UNAIDS (2004) show that the pattern of early infection among 
young women peaked among the age group 25-34, while in men the majority of 
cases occurred slightly later in life, peaking at 30-39 years. These groups are 
mostly unable to play an active economic role or provide for their families. 
The results show that the majority of patients receiving ARV especially in urban 
areas have to travel for more than one hour to reach the hospital. Most of the 
respondents (90%) pay up to 400TSH (0.45 USD $) for the return ticket. 
Interviewees stated that it is not always affordable to pay for the transport every 
time. When asked what they do in cases when they had no money for transport, 
up to 80% said they borrow from either relatives or friends. In rural areas, 99% 
of the patients walked long distances (more than one hour) to reach the facilities. 
66 
Figure 6: Employment status of the patients utilizing ARVs 
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As it is shown in Figure 6, only 18% of the patients utilising ARV are employed. 
The majority of patients utilising ARV (82%) are not employed. It was difficult to 
make a comparison with the general population because there were no data in 
TDHS 1999 showing the overall employment status in Tanzania. However, the 
findings shown above could be misleading since in developing countries like 
Tanzania, self-employment and informal economic activities are more common 
than formal employment. When asked how they make their living, most of the 
respondents stated that they were either self employed or ran small businesses. 
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Figure 7: Head of Household 
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• ARV users 
Figure 7 shows the distribution of gender of households heads across ARV users 
and TDHS respondents. The results show that the majority of households (62%) 
of patients on ART were headed by males as compared to females (38%). 
However, across the general population (TDHS sample) relatively more 
households were headed by males (77%). When the heads of the households 
were stratified into rural and urban settings, the picture remained the same, as 
shown in Figure 8 and figure 9 below. However, the gender pattern seems to be 
more prominent in rural areas than in urban areas. This may be explained by the 
fact that women in urban areas are able to run their own families without 
depending on men because some are more educated, availability of more 
employment opportunities and adoption of western culture of living. Also divorce 
is more common in urban than in rural because of the same reasons of education 
and more employment opportunities. 
Figure 8: Head of Household in both settings (ruraUurban) for ARV users. 
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Figure 9: Head of Household in both settings (rural/urban) from DHS 1999 
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From these findings one could conclude that the gender of the household head 
plays a role in determining utilisation ART by household members. 
5.3 The knowledge and attitude of HIV patients towards ARV in Tanzania 
The facility based questionnaire was used to ask respondents about sources of 
information on the provision of free ARV drugs and its perception. It was found 
that the majority of the participants (98%) had heard about free ARV provision 
either from clinic personnel, community health workers or family and friends. The 
probable reason is due to the fact that most of the patients, as discussed 
previously, start receiving drugs when they are already in the advanced stage of 
the disease with other co-morbidity factors. This means that they will start ARV 
after being advised by clinical personnel or family members to test for HIV since 
their conditions are worsening. 
Media sources such as newspapers, leaflets, radio and television were not a 
common source of information about ARV with the exception of only 1% of the 
respondents with higher socio-economic status. From this information, one can 
therefore argue that either public sensitization of ARV through the media is still 
inadequate or that probably many people who need such information do not have 
access to the media due to financial constraints. It is evident however, from the 
TDHS that the possession of radio and television is exclusively associated with 
the high socioeconomic status. 
In the case of ARV perception, respondents were asked to talk about what they 
knew about antiretroviral drugs for HIV/AIDS. Most of the respondents said that 
the drugs are useful in prolonging life because they had improved their health 
making it possible for them to resume work and gain confidence. However, some 
respondents from the rural setting said that the drugs give them appetite to eat 
more than normal and that is why some of the people are scared to start drugs 
because they do not have enough food. The following are some quotes taken 
from the respondents. 
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"Oyo (wow), these drugs are good because they help in extending our life. When 
I started taking them, I started eating normal, gained energy, and I don't have 
any complains at the moment. Look at me now (smiled a bit), if I meet a person 
who saw me three months ago, he will not believe". (Woman in the FGD from 
Dares Salaam region). 
"I know that these drugs do not heal completely but thanks to doctors who found 
these drugs and I always pray for them so that God will give them idea of getting 
drugs that can heal completely. What I know is that if I was to die today then I will 
die after ten years. So don't you see that it helps to prolong life and we will be 
able to take care of our children"? (Man in the FGD from Kagera region). 
"You see, when someone starts using the drug, the virus is paralyzed and it can 
no longer multiply at the rate it used to before the antiretroviral drugs. This 
therefore reduces the opportunistic diseases that were so common and a person 
is able to live longer. So, although it does not mean that the person is cured 
completely but his/her life is extended". (Community leader in the FGD from Dar 
es Salaam region). 
"My friend had lost weight, was not feeling comfortable going out with us and his 
family was suffering because they were depending on him. Then we heard of 
ARV and advised him to come here and start ARV. I can tell you that, if you see 
him now, you can't believe that the guy is HIV positive and he is back to 
work"(Man from Kagera region) 
"This drug is very useful if is used accordingly but the problem is that, some 
patients do not follow the instructions. We tell them that don't ever miss to take 
the drug and stop drinking alcohol but when we visit them, you find them drinking 
alcohol sometimes. I think it is because of the psychological problems. But for 
those who follow the instructions, they are improving and they look great. I think 
you can see some of them here (Laughter at the back)". (Medical Doctor from 
Dar es Salaam region) 
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''The problem with these drugs is that you have to eat too much. When you start 
these drugs you eat two times more than normal. So my friend stopped taking 
drugs because he could not get food for him and his family. But you see now, he 
died last month and left the wife with four children" (Man from Kagera region). 
5.4 Factors that contribute to the utilization of free antiretroviral drugs in 
public facilities in Tanzania 
Respondents were asked the factors constraining utilization of these drugs for 
those who need them. Most of the reasons given by respondents were that, 
people are scared of testing for HIV due to stigma, discrimination and alienation. 
In addition, some of the respondents indicated that they were not aware of the 
availability of free ARV drugs. However, it was pointed out that, some who are 
aware of these drugs feel shy to stand on queue waiting for the drugs because of 
the fear of being recognized by other people. The other reason hindering 
utilisation was that people could not afford to travel to health facilities more 
especially those that were residing in remote areas. 
As regard to the availability of ARV, most of respondents say that the drugs were 
available in most hospitals. However, those in urban areas complained about the 
transport cost they incur while in rural areas, individuals complained about the 
long distance they had to cover by walking to the hospitals. The following 
statements from the focus group discussions underline the concerns: 
"Sometimes I decide not to go because I don't have 800 shilling (USD 0.85) for 
the return ticket and when you go there, you have to wait for more than 5hours 
so you will have to buy food so I can not go there everyday and you see I am not 
working." (Woman from Dares Salaam region). 
"I walk for about one and half hours to reach the hospital. I used to have a bicycle 
but now my uncle took it. I have got no alternative, I have to go and take drugs 
otherwise I will die. Thanks God that I have strength to walk that long distance. 
But now imagine people who are seriously sick here in the village and can not 
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walk. There is no way they can go there and sometimes they have to go weekly, 
it is impossible. (Man from Kagera region) . 
'We have tried to ask them (medics) to put the patient on the same day for ant-
TB drugs and ARV but they don't want to listen so you find a person traveling 
twice in a week to the same hospital while he/she should have gone once, this is 
burden to the patient." (Health care provider from Dares Salaam region) 
"Patients have to walk a long distance for these drugs and some of them are 
weak so there are some other days they decide not to go because they can not 
walk for such a long distance." (Community member from Kagera region). 
"Sometimes even your friends/ neighbors get tired of helping us because you 
keep on borrowing money everyday and you can not pay back so sometimes you 
go and ask for the money from your relatives. Sometime the relatives don't offer 
money on the actual day and they tell you to go there next week because they 
know you will go there again." (Woman from Dares Salaam region). 
"Some people do not go for ARV because they are not aware of the availability 
of these drugs. Some who are aware of these drugs feel shy to stand on queue 
waiting for the drugs because other people will know them when they see them." 
(Man from Kagera region). 
The reason for choosing the above quotes was because they were commonly 
repeated by most participants in the FGD. 
5.5 Household assets ownership among patients receiving ARV 
Since the aim of the study was to identify the socioeconomic status of those 
accessing ARV, household asset ownership was used as a criterion to 
differentiate socio-economic quintiles. By using principal components analysis 
(PCA), the weights of asset variables were generated using the reference 
sample. Quintiles were generated on the basis of the asset scores. This section 
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specifically looks at asset ownership among ARV patients and their household 
characteristics, given their categorization into quintiles determined on the basis of 
the reference sample. 
As it may be expected, asset ownership differs between the rural and the urban 
sample. The data presented in Table 2 & 3 indicate that urban and rural 
households have almost the same percentage of radio ownership. However, 
more than half of the households of urban patients own televisions as compared 
to only 4% of the rural sample. Also, refrigerators are uncommon in rural areas. 
Bicycles are more common in rural areas compared to urban areas, while cars 
and motorcycles are almost exclusively owned by urban households. The 
percentage of households with access to piped water is much higher in the urban 
areas (83. 76 percent) compared to the rural areas (0.68 percent). The traditional 
pit latrines are commonly used in both settings with 84.2% in rural areas and 
63% in urban areas. Flush toilets are almost exclusively owned by urban 
households. The type of toilet facility has implications on the household's health 
status. It is important to note that, households without a proper toilet facility are 
exposed to the risk of diseases including dysentery, diarrhea and typhoid fever. 
The common type of floor materials in rural areas was earth/sand/dung with 
almost 85% comparing to only 4.5% urban counterparts. Most of urban 
households (76%) have floors made of cement. Table 2 shows the five quintiles 
in ascending order from the lowest to highest quintiles i.e. 01-lowest, 02- low, 
03-middle, 04-high and 05-highest. 
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Table 2: Household assets ownership in urban districts (Dar-es-Salaam region) 
~ariable Q1 Q2 Q3 Q4 as Total 
Have flush toilet O.Oo/c 6.3% O.Oo/c 16.02% 63.4°/c 37.01 °/c 
Have traditional pit latrine 1 00.0°/c 93.75°/c 1 00.0°/c 84.01% 36.66o/c 62.98°/c 
Have cement floor 1 00.0°/c 75.0% 3.4o/c 4.0% 0.0°/c 10.4°/c 
Have ceramic tiles 0.0°/c 25.0% 96.5°/c 96.0% 75.6°/c 76.6°/c 
Have earth/sand floor 8.5°/c 0.0% O.Oo/c 0.0% O.Oo/c 4.5o/c 
Have other floor materials 0.0°/c 0.0% 0.0°/c 0.0°/c 15.8o/c 8.4o/c 
Have piped water in residence 0.0°/c 68.7% 93.0o/c 88.0% 84.0°/c 83.76o/c 
Have public tap 1 00.0°/c 18.75°/c 6.9°/c 12.0% 9.7°/c 11. 7o/c 
Have protected well in residence 0.0°/c 12.5% O.Oo/c 0 .0% 6.0°/c 4.54°/c 
Have car truck 0 .0°/c 0.0% O.Oo/c 0.0% 18.3o/c 9.74°/c 
Have motorcycle 0.0°/c 0.0% 0.0°/c 0.0% 14.63o/c 7.79o/c 
Have bicycle O.Oo/c 6.25% 0.0°/c 8 .0% 8.53°/c 6.49o/c 
Have electricity 0.0°/c 6.25% 1 0.3°/c 84.0% 97.5°/c 68.18°/c 
Have Television O.Oo/c 0.0% 0.0°/c 20.0% 89.0o/c 50.64°/c 
Have radio 0.0°/c 12.5% 44.8°/c 84.0% 100.0o/c 76.62°/c 
Have refriQerator 0.0°/c 0.0% 0.0°/c 0.0% 73.2°/c 38.96°/c 
Table 2 (ARV patient data) shows that, in the urban setting, the main type of 
toilet facility in the highest quintiles is the flush toilet (63.4%). Households from 
the highest quintile have ceramic tiles (75.6%). Piped water in residence, as a 
source of drinking water is associated with the highest socioeconomic group and 
it concentrates more in 03, 04 and 05. Individuals from the highest quintiles 
possess more cars/trucks and motorcycles compared to the rest of the wealth 
quintiles. Possession of bicycles, refrigerators, televisions, radios and electricity 
is also highly associated with the highest income group. 
It is also important to observe that the type of toilet facility in the low and lowest 
quintiles is mainly traditional pit latrine (94% and100% respectively) and their 
houses are mainly cement rather than tiled floors. None of the patient from the 
lowest quintile had electricity and the main source of drinking water was public 
tap (1 00%). None of the households from the low and lowest quintiles possessed 
cars/trucks or bicycles. Only 6.25% of households from the low quintile had a 
bicycle. None of the households in the lowest quintiles owned a refrigerator, 
television, or radio. However, 12.5% of individuals from the low quintile owned 
radios. 
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Table 3: Household assets ownership in rural districts (Kagera region) 
~ariable p1 p2 03 04 ps rrotal 
Have flush toilet p.O% p.O% 0.0% 0.0% f4.5% ~.05% 
Have traditional pit latrine 100.0% 1 00.0°/c 100.0% 100.0% [65.7% [84.24% 
Have ventilated improved latrine P.O% p.o% 0.0% 0.0% ~9.8% 13.69% 
Have cement floor p.O% p.O% 0.0% 0.0% 1.49% p.68% 
Have ceramic tiles p.O% p.O% 0.0% 0.0% 131.3% 14.4% 
Have earth/sand floor 100.0% 1 00.0°/c 100.0% 100.0% [65.7% [84.24% 
Have other floor materials p.o% p.o% 0.0% 0.0% 1.5% p.68% 
Have piped water in residence p.O% p.o% 0.0% 0.0% 1.49% p.68% 
Have protected well in residence p.o% p.o% 0.0% 0.0% [67.16% [38.82% 
Have public tap 100.0% 1 00.0°/c 100.0% 0.0% ~8.3% [67.12% 
Have rain water p.o% p.o% 0.0% 69.64% 1.5% p.68% 
Have car truck P.O% p.o% 0.0% 0.0% 1.49% p.68% 
Have motorcycle P.O% p.o% 0.0% 0.0% 1.49% P.68% 
Have bicycle P.O% 1 00.0°/c 0.0% 100.0% 138.8% ~8 .76% 
Have electricity P.O% P.O% 0.0% 0.0% 19.4% [8.90% 
Have television p.o% p.o% 0.0% Q.O% ~4.54% 14.10% 
Have radio p.o% p.o% 100.0% 100.0% [88.0% 178.76% 
Have refrigerator p.o% p.o% 0.0% 0.0% 12.9% 1.36% 
Table 3 shows that only 1.49% of ARV patients from the highest quintile in the 
rural setting had cars/trucks/motorcycles. The main type of transport in the rural 
setting is bicycles and these are mainly owned by individuals from low and higher 
quintiles. However, the ownership of bicycles is also associated with higher 
socioeconomic status because as it is shown above, none of individuals from 
lowest quintiles had a bicycle. 
The possession of durable goods like refrigerator, television is exclusively 
associated with the highest socioeconomic group. However, lowest and low 
quintiles did not have radios while the possession of a radio in middle quintiles 
was 100%, higher quintiles (1 00%) and highest quintiles (88.0%). None of the 
households in the lowest, low, middle and higher quintiles had electricity; 
however it was relatively common in the highest quintiles with almost 19.4%. 
76 
Piped water in the residence as main source of drinking water was exclusively in 
the highest quintile with only 1.5% of the households accessing piped water while 
for the open public, the well was the main source of drinking water in all quintiles. 
Traditional pit latrine and improved ventilated latrines were the most common 
toilet facility in all quintiles while flush toilets were exclusively for the highest 
quintile with only 4.5%. Cement floor materials were exclusively for the highest 
quintile with only 1.5%, while the earth/sand was the main floor material in most 
households across the quintiles. 
5.6 Utilization of ARV by different settings (urban vs. rural) 
The utilization of ARV by different quintiles (socioeconomic status) in rural and 
urban settings is shown below in Figures 10 and 11 below. This presentation 
ultimately reflects the socio-economic structure of ART patients in the rural and 
urban settings. The results reflect the degree to which the poor benefit from the 
free provision of ARVs in public facilities. 
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Figure 1 0 shows that there are extreme differences in the socio-economic 
structure of ART patients between the two different settings. The findings show 
that socioeconomic groups are not evenly represented in free ARV utilization, 
especially in urban districts. In rural districts, the ARV utilization is concentrated 
in the middle or third quintile (38.40%) and high or fourth quintile (38.40%). In the 
rural sample, there was no individual belonging to the second quintile utilizing 
ARV. ARV utilization in urban districts is concentrated in the two upper quintiles 
i.e. the fourth or high quintile (29.20%) and fifth or highest quintile (69.50%). 
The above results indicate that free ARV provisions in urban districts may be less 
equitable compared to rural districts in terms of socioeconomic status because 
those with higher socioeconomic status are more favored than their counterparts. 
However, in rural districts, the findings show that ARV provision caters not only 
for individuals from the highest quintiles but also those from lowest quintiles i.e. 
Q1 (15.80%). However, those in higher quintiles especially in the middle and 
higher quintiles have higher utilization rate than those in lowest quintile in rural 
districts. Overall findings in both settings show that those in highest quintile have 
higher utilization rate of free ARV than those from lowest quintiles. It should be 
noted however that, lacking information on need according to the socioeconomic 
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status of individuals could make these findings not conclusive. The results 
reflected in Figure 10 may overstate inequities in the provision of ART, as the 
socio-economic quintiles were constructed on the basis of the reference sample 
at the national level. The extreme results suggest that it may be more 
appropriate to calculate separate asset indices for Tanzania's rural and urban 
areas. 
In order to avoid the misleading results based on existing different lifestyles 
between the two settings and also to make the results more precise, two 
separate rural and urban indices have been calculated, as the socio-economic 
structures of rural and urban differ dramatically and thus asset ownership. 
Separate quintiles were formed accordingly. The categorization of the patient 
samples into these revised socio-economic groups are shown in Figure 11 
below. This presentation avoids the bias that occurs because of the differences 
in living standards between urban and rural individuals. 
Figure11: Percentage of people on ARV by different settings and wealth quintiles 






ca - 30.0 s:: 
Cl) 






Q2 (Low) Q3 (Middle) Q4 (High) Q5 (Highest) 
Quintiles 
I o rural ~urban I 
Figure 11 shows that still ARV utilization in urban districts follows an ascending 
pattern from lowest to highest quintiles while rural districts caters not only 
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individuals from the highest quintiles but also those from lowest quintiles have 
higher utilization rate (13.6% of ART patients fall into the first quintile) despite of 
the split into two different indices. However, as compared to the lowest quintile, 
patients in the middle and highest quintiles are overrepresented in rural districts. 
The findings still show that socioeconomic groups are not evenly represented in 
free ARV utilization, especially in urban districts. However, in urban districts, 
there are some patients who belong to the first (1.3%) and second (10.3%) 
quintiles who are tilizing free ARV. The third and fourth quintiles have almost 
similar are almost evenly represented with 18.7% and 16.1% respectively. 
However, 53.3% of all ART patients in the urban sample belong to the highest 
quintile. In rural districts, the ARV utilization is also concentrated in the highest 
quintile with 46.3%, which in terms of living standards is now different from the 
highest quintile in the urban setting. 29.3% of ART patients are from the rural 
third quintile. It is interesting to observe again that based on the rural asset index 
the individuals from the lowest quintiles still seem to underutilize free ART 
services (13.6% of patients fall into the first, 2.0% into the second quintile). 
Overall, findings from both settings show that there are relatively more individuals 
from the better-off socio-economic groups in the specific settings who benefit 
from the provision of free ARVs. Since the sample size was relatively small, the 
overall findings can not be conclusive, however. 
Table 4: Different facilities in urban setting by different wealth quintiles based on 
pooled urban data 
Quintiles Amana Mwananyamala Temeke Total 
Hospital Hospital Hospital 
01 0 {0%) 0 (0%) 2 (4%) 2 (1.3%) 
02 0 (0%} 0 {0%} 0 (0%) 0 (0%) 
03 0 (0%) 0 (0%) 0 (0%) 0 {0%} 
04 9 (16%) 21 (41%) 15 (32%) 45 {29.2%} 
05 47 (84%) 30 (59%) 30 (64%) 107 {69.4%) 
Total 56 (100%) 51 (100%) 47 (100%) 154 (100%) 
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Table 4 reflects the findings based on a national-level asset index for the study 
sites in the urban area. The two patients from the sample who fall into the lowest 
socio-economic quintile were treated at Temeke Hospital. The utilization of ARV 
facilities is associated with higher socioeconomic status. 
Table 5: Different facilities in rural setting by different wealth quintiles based on 
pooled rural data 
Quintiles Ndolage Nyakahanga Rubya Total 
Hospital Hospital Hospital 
01 8 (17%) 9 (20.5%) 6 (11 %) 23 (15.75%) 
02 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
03 20 (43.4%) 15 (34%) 21 (38%) 56 (38.35%) 
04 15 (32.6%) 18 (41%) 23 (42%) 56 (38.35%) 
05 3 (6.5%) 2 (4.5%) 5 (9%) 11 (7.5%) 
Total 46 (100%) 44 (100%) 55 (100%) 146(100%) 
Table 5 indicates that the distribution of access to free ARV in rural facilities also 
caters for individuals from lower socioeconomic status. However, the percentage 
of individuals utilizing free ARV increases with the high socioeconomic status 
especially in the middle and higher quintiles. These findings again support the 
results shown in Figure 10 that, the individuals from higher socioeconomic status 
have higher utilization rate of ARV provision comparing to the low counterparts. 
The pattern is consistent across the three facilities. 
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Table 6: Percentage of patients on ARVs by gender pattern and wealth quintiles 
based on pooled rural and urban data 
Ouintiles 
Urban (Dares Salaam) Rural (Kagera) 
Male Female Male Female 
01 (Lowest) 1 (1.7%) 1(1.1%) 11 (14%) 12 (18%) 
02 (Low) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
03 (Middle) 0 (0%) 0 (0%) 28 (35%) 28 (42%) 
04 (High) 12 (20.3%) 33 (34.7%) 33 (42%) 23 (34%) 
05 (Highest) 46 (78%) 61 (64.2%) 7 (9%) 4 (6%) 
!Total 59 (100) 95 (100) 79 (100) I 67 (100) 
Table 6 presents the socio-economic pattern of patients on ARVs in the rural and 
urban facilities by gender. Despite the overall higher share of female patients in 
the urban setting and male patients in the rural setting there is no consistent 
gender pattern across socio-economic quintiles in either the rural or the urban 
sample. 
The detailed results show that ARV provision in all facilities in both settings 
favour the better-off in society. 
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CHAPTER SIX: DISCUSSION 
6.1 Overview 
This chapter discusses the findings around the socio-economic structure of 
patients utilising ARV in public facilities in Tanzania. The summary of the findings 
will be presented. The application of principles of equity will also be briefly 
discussed in this chapter. 
6.2 Provision of free ARV policy in Tanzania 
The main reason for providing free ARV in public facilities in Tanzania is to 
improve the quality of life of those living with HIV/AIDS. This is reflected in a 
statement by the Tanzanian government. One of the goals of the Tanzania Care 
and Treatment Five-year Plan is to "increase access of ARV to HIV patients, 
provide quality, continuing care and treatment to as many HIV positive residents 
of the United Republic of Tanzania as possible, building one of the careful 
planning already completed by the Ministry of Health and the Tanzania 
commission for AIDS" (GOT/MOH, 2003:21). 
The study revealed that all HIV/AIDS patients on ARV in Tanzania are on first 
line regimen. This is due to the fact that the free ARV roll-out policy in Tanzania 
began late 2004 and according to WHO recommendations, a standard 
combination of drugs known as first-line should be given to those who have just 
started on the ARV treatment. In Tanzania's policy, before treatment failure is 
presumed and a particular regimen discarded, every effort should be made to 
rule out causes other than drug resistance. Patients should be evaluated for 
correctable factors such as inappropriate dosing schedules, drug interactions that 
may reduce the efficacy of some of the ARV drugs, non-adherence due to side 
effects and evidence of mal-absorption (NACP 2005). Since it takes time to take 
all these factors into account, this could explain the reason why the majority of 
ARV users are on first line regimens. Also, one could think of the higher costs 
involved to purchase the second line drugs in developing countries as discussed 
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previously. The criteria for eligibility to access the free ARV in Tanzania are 
clearly outlined by the Ministry of Health and reflected in the key informant 
interviews as reported above. However, the socioeconomic status of patients 
receiving ARV is not one of the criteria for eligibility, which results in an over 
proportional share of patients from the higher socio-economic strata. Also the 
criteria for disclosure i.e. to disclose their HIV status to at least one friend or 
family member before starting the treatment could cause the barrier to utilise the 
ARV to some patients who are not ready or feel shy to disclose their HIV status 
to avoid the alienation. 
6.3 ARV utilisation by gender in Tanzania 
Findings from the study showed that women utilise free ARV more (54%) than 
men (46%) across all study sites visited, even though there is a different pattern 
between the rural and urban sites. Probably this is due to two reasons: Firstly 
the HIV infection rates in Tanzania are higher among women than among men 
(NACP 2005). Also women are more sensitive regarding their health than men, 
so probably they respond more positively on the call for ARV than men. These 
findings are supported by the studies conducted by Barongo et al. (1992) and 
Berkley et al. (1990). It was found that the factors contributing higher risk of HIV 
among women in Tanzania includes the low social status of women and 
economic dependence on men and these factors affect women's capacity to 
determine their sexual lives with sexual decision making being constrained by 
coercion and violence (MOH 2004). However, there are no biological factors 
which make women more susceptible to HIV infections. Another study done by 
NACP 2005 revealed that women are more likely to go for voluntary counseling 
and testing (VCT) than men, hence are more likely to utilise free ARV, as VCT is 
a prerequisite for access to free ARV. The reason for women to have higher 
utilisation rate could be also due to the fact that while men experience stigma of 
exposing their HIV status more, women get scared of HIV infection because they 
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fear to leave their children orphaned, so they opt to test for HIV and start ARV 
early so that they can live longer and take care of their children. 
The discussion above implies that the free ARV utilization in Tanzania is 
relatively equitable from a gender perspective. 
6.4 ARV Utilization by age in Tanzania 
The findings from the study show that the age group between 30 and 40 utilizes 
ARV more than other age groups. This applies to both rural and urban settings. 
The reason could be the fact that in Tanzania the most affected age group in 
both setting was age of 30-40 with more than 40%. These findings tie in with the 
UNAIDS findings which showed that the pattern shows early infection of young 
women, with reported cases peaking from age 25-34, while in men the majority of 
cases occur slightly later in life, peaking at 30-39 years (UNAIDS, 2004). These 
groups are unable to play an active economic role or provide for their families. 
One can argue that the free ARV provision in Tanzania with regard to age groups 
is relatively efficient because this age group has the largest and most productive 
segment of the labor force. Hence by having higher utilization rate of ARVs on 
this age group will have implications for the labor force supply as well as the 
Tanzanian economy in general. 
6.5 ARV Utilization by educational level in Tanzania 
The majority of those utilizing ARV (almost 60%) in the study had primary 
education. Those with no education (never attended school) and with secondary 
education had almost similar level of ARV utilization while those with tertiary 
education were the least. When comparing the educated (all levels of education) 
and non educated (those who never attended school) participants it becomes 
obvious that the educated ones are utilizing more ARV (almost 80%) than the 
non- educated ones (20%). Note that the educated and non educated ones in 
Tanzania regardless of their level of education are 87% and 13% respectively. 
The possibility for the non-educated being overrepresented among ARV patients 
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compared with the general population is not excluded. These findings remained 
consistent, even when the results were stratified into rural and urban settings. 
This could be due to the differential access to information between the groups, as 
reflected by access to magazines, newspapers and other news media. However, 
evidence from the focus group discussion (FGD) indicated that those with a 
university degree may not feel comfortable standing on the queue waiting for 
drugs, so they prefer to go to the private facilities. Also they may have well-paid 
jobs and therefore can afford the private sector .The confidentiality in public 
facilities may also not be guaranteed. 
With regard to whether the provision of ARV by education level is equitable or 
not, the study results imply that it is relatively equitable because the majority of 
those utilizing free ARV services are those with either primary education or with 
no education. This mirrors the statistics from NACP 2005 which showed that the 
majority of people with HIV are non-educated especially those in rural areas. 
However, one cannot derive an ultimate conclusion because, as discussed 
earlier, the utilization pattern may just reflect that those with higher education opt 
to attend the private facilities. 
6.6 ARV utilization by employment status 
As it was shown in the previous chapter, only 18% of the patients utilising ARV 
were employed. The majority of patients accessing ARV (82%) are not 
employed. The unemployed who are also more infected with HIV diseases make 
their living by running their small business, which are not always sustainable. 
Some patients are unemployed so they are totally depending on their relatives 
(NACP, 2005) and the situation was worse in rural areas where more than 95% 
were unemployed. The findings matched with NACP 2002 which show that 
majority of HIV patients in Tanzania are unemployed. The reason could be that 
they have ample time since they have no serious issue keeping them busy. Also 
the unemployed ones have financial constraints so they might not have money to 
86 
buy condoms and other contraceptives and do not access information on HIV 
because they do not have TV, Radio and do not know how to read and write. 
With regard to whether the ARV provision by employment status is equitable or 
not, one could argue that it is equitable since the majority who do not have 
steady income to pay for their drugs have higher utilization rate of ARV than their 
employed counterparts. 
6.7 ARV utilization in both settings (urban vs. rural) 
As shown in the previous chapter individuals from the higher socio-economic 
status form a bigger share of ARV users than individuals from lower socio-
economic strata. However, the relation between these settings and their needs 
were not analyzed in this study so any equity judgment derived from this study 
can only be based on a very general notion of social justice according to socio-
economic status. 
Based on the data obtained from the study sample, it was found that the 
individuals with primary education and those with no education have the higher 
level of utilizing ARV among the population . This study due to some limited 
information was based on the assumptions that those with no education 
represent individuals from lowest quintile and those with primary education 
represent the lower quintiles and from that assumption, one can conclude that 
free ARV provision is more equitable in rural districts comparing to the urban 
counterparts. Another argument is that individuals from the lowest quintiles are 
economically disadvantaged and vulnerable to diseases. These groups also have 
lower health status compared to those from highest quintiles. This implies that 
the principle of vertical equity is not achieved because these vulnerable groups 
are underserved. One could also think of the maximin principle of social justice 
and conclude that ARV provision in both settings is not fair since it is clear that 
those who are most disadvantaged in terms of health status and socio-economic 
status are not prioritized. 
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However, the purposive selection of facilities could have induced any bias 
because the study areas are not really representative of the average rural and 
urban populations in Tanzania. 
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CHAPTER SEVEN: CONCLUSIONS AND POLICY RECOMMENDATIONS 
While the provision of ART has substantially improved the prognosis of HIV-
infected patients in industrialized countries, in resource poor settings in Africa, 
Asia and South America where 90% of people with HIV/AIDS live, access to ARV 
continues to be limited. 
The study intended to help answer the question of who are the beneficiaries of 
the free antiretroviral provisions in public facilities in Tanzania in relation to 
socioeconomic groups in rural and urban settings, i.e. "do the poor benefits?" 
The study has found that non-educated individuals and those with primary 
education, unemployed individuals, and age groups between 30-40 years have 
higher utilization rate of ARVs compared to their counterparts. Furthermore, the 
comparison among these groups was done in relation to their relative occurrence 
in the overall population using the TDHS 1999 and the underlying reasons for 
the greater access among these groups are discussed in previous chapter. 
However, in rural settings it was found that some percentage of individuals from 
the lowest quintile are benefiting from the ARV provision compared to urban 
settings where there were no representatives from the lowest quintile. It can be 
concluded that those from the lowest socioeconomic group in urban settings may 
only start benefiting after those from the highest socioeconomic group have 
benefited. 
However, the information received from the focus group discussions showed that 
not only do the supply factors influence the degree of equality in the utilisation of 
free ARV drugs in Tanzania but also there are crucial factors from the demand 
side that play a big role in the distribution of these drugs. For example, some 
patients were scared to take ARVs because they increase the patients' appetite 
and thus tend to increase food expenditure. Also some patients believed that 
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they have been bewitched so they would rather opt for traditional healers than 
taking ARVs. 
Regarding to the above findings, one can conclude that the utilization of free 
ARV provision in Tanzania does not reflect the level of need and thus should be 
judged unfair in terms of vertical and horizontal equity. Also, in the light of the 
maximin principle of social justice, the utilization pattern would be judged unfair, 
because the least economically disadvantaged and vulnerable are not prioritized. 
In summary, the study has the following policy recommendations, 
• The standard assumption that the poor are always the principal 
beneficiaries of publicly funded health services is clearly incorrect and 
must be replaced by vigilance to ensure that the traditional pattern of 
higher service coverage among upper income groups does not continue. 
• There is need for improving the free ARV programmes in favor of the poor 
and least economically disadvantaged and thus for improving vertical and 
horizontal equity in ARV provision in Tanzania. 
• More research is needed to clearly establish the relationship of 
socioeconomic characteristics of those accessing ARV and improve the 
understanding of service provision in urban and rural settings. This 
information will help policy makers to improve the effectiveness of ARV 
programmes aimed at reaching the poor, not only in terms of treatment but 
also prevention of HIV/AIDS. Also, the resource allocation formula can be 
used to design a policy in such a way that ARVs are provided fairly across 
the societies. 
• The government also needs to sensitize the public about existence, 
importance and the availability of antiretroviral drugs widely. The findings 
of this study showed that the majority of patients (90%) knew about 
existence of ARV through clinical personnel and only few patients (less 
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than 1 %) had learned about the programme from radio, television or 
leaflets. 
• There is a need for the government, whenever necessary and especially 
for those who can not get food, to support the provision of food and basic 
services. This is most important in rural areas where people can hardly 
afford to buy food and yet are receiving ARV. The response from one 
participant in the focus group discussion in rural areas said that other 
patients are scared to take ARVs because they increase appetite. 
• The government should initiate national campaigns against HIV stigma all 
over the country through national celebrities and popular people who are 
HIV positive and are already on ARV treatment to give their views on the 
disease and its treatment. This will reduce stigma in the context of 
HIV/AIDS and will improve the utilisation of voluntary counseling and 
testing for HIV. Similarly, the government should alert the public especially 
in the rural areas on the key aspects of HIV transmission and promote the 
incorporation into behaviour and practices. 
• There is a need for the government to ensure that the ARV programmes 
work according to the set priorities. This can be achieved by developing 
tools that help in constantly monitoring and evaluating the programs to 
inform policy makers whether the least economically disadvantaged and 
vulnerable are reached. 
• Further studies have to be conducted to determine why some 
socioeconomic groups are not utilizing free ART services that are 
available in their area. 
In Tanzania, the provision of free ARV is still in its infancy and the need for 
scaling-up is as urgent as ever. The need to set priorities that will allow easier 
accessibility of these drugs in such a way that will target and reach the least 
disadvantaged groups is highly needed. Macklin (2004) also concluded by 
91 
insisting that making decisions in priority setting should take into 
consideration all relevant ethical and equity principles to ensure that all 
human rights obligations are respected, protected and fulfilled. 
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APPENDIX A: Consent letter for Key Informants 
Dear interviewee, 
You are requested to participate in a study about who benefits from 
free/subsidized antiretroviral drugs in Tanzania. The information provided by you 
will be taken as confidential. Your participation is entirely voluntary and you have 
the right to withdraw from the process of the interview whenever you wish to. The 
information provided will only be accessible to responsible persons and no 
personal information will be required from you. 
The aim of the study is to fulfill the requirements for my Master's degree in Public 
Health. It will also help to provide information to policy makers on how to develop 
suitable guidelines on improving access and fairness in the provision of 
antiretroviral medicine. 
Declaration 
I have read and understood the nature of the study in which I am participating. I 
therefore agree/ do not agree to participate. I also give I not give permission for 
this interview to be taped by the interviewer 
Signature of respondent: 
Date: 
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APPENDIX B: Key Informant Interview Schedule 
Which type of ARV programmes are you involved in? 
Are the ARV drugs provided free or on a subsidized basis? 
When were these programmes started? 
Please explain what are the objectives underlying the provision of free or 
subsidized ARV drugs? 
What are the criteria for eligibility to access free ARVs? 
What groups of people are these ARV programmes mainly targeting? 
How do you know that those who are accessing the drugs are target people and 
how do you maintain it? 
What do you think are the barriers to all eligible for free/subsidized treatment not 
accessing ARVs? 
How can these barriers be removed? 
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APPENDIX C: Informed Consent form for Study Subjects 
My name is Amos Kahwa, a Master's student at the University of Cape Town 
(UCT) in South Africa. I am conducting a study to evaluate who benefits from free 
antiretroviral drugs in Tanzania. This is to fulfill the requirements toward the 
award of Masters of Public Health. It is also my hope that the study will have 
necessary information to policy makers who may in turn improve the services you 
are receiving. The findings of this study will also be provided to you. 
The information you are giving me will be treated as confidential and will have no 
any impact on the treatment you are receiving at this facility. The completed 
questionnaires will be accessible to responsible persons. By assuring you the 
confidentiality, there are will be no names or any other personal identification 
requested from you. In this study, you have the right to agree to participate or not 
to participate. You also have the right to withdraw from the study at any stage 
whenever you wish to. 
Consent: I agree to participate in the study. 
Signature: ............ ...... .. ... ..... .. Date ......... ....... .... . 
99 
APPENDIX D: Study Questionnaire 
Part A 
ID Number: _____ _ 
Name of facility: 
District __________ _ 
URBAN 1 
RURAL 2 






3. Level of Educatio : Please tick appropriate box 
Never attended school 
Primary level education 
Secondary level education 
Advanced secondary school (High Level) 
Tertiary education, including undergraduate and diploma level 







4. Where do you live? ____ _ 
5. How do you come to the clinic/ facility/Hospital? 
1) Walking 
2} Traveling 
6. How long do you take to reach this clinic/ hospital /facility? 
Less than 15 min 1 
15-30 minutes 2 
30 mins to one hour 3 
Over one hour 4 
7. This is applicable, if Q 5 above is traveling. Do you travel by public or private means? 
Private 
Public 2 
a) If public how much does it cost you to travel here? (Amount in TSh) __ _ 
b) Is it affordable to pay for the transport every time you need to come for treatment? Yes/ No 
c) If No, what do you do if it happens that, you don't have money for transport? ___ _ 
8. Question 
a) Are you employed? 
Yes 1 Go to questions 8b and Be 
No 2 Go to question 9 
b) Where do you work? ____ _ 
c) What is your position there? _____ Go to question 10 
9. In the past 7 days have you had any work for pay? 
Yes 1 Go to question 1 0 
No 2 Skip to question 11 
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10. What kind of work was it? ____ _____ go to Q. 13 
11. When was the last time that you worked for money? 
Within the last month 1 
Within the last 3 months 2 
Over six months ago 3 
13. In the past 1 0 days have you had money available from other sources than work? 
Yes 1 Go to question 11 
No 2 Skip to question 12 
14. What are the sources ____ ? 
15. What is the number of people living in the household (excluding visitors)? _ _ _ 
16. Who is the head the household? Male or female ____ _ 
17. What is the main source of drinking water for members of your household? 
Piped 1 Public tap 
IJo In residence 1 putside residence 
ppen well 2 In yard/plot 1 putside yard 
Protected well 3 In yard/plot 1 putside yard 
Borehole 4 In yard/plot 1 putside yard 
~pring water 5 
Rain water 6 
~ anker truck water 7 
River, canal or surface water 8 
Bottled water 9 
~ater from gravity flow scheme 10 
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18. What Type of toilet does your household have? 
Flush toilet (own) 1 
Flush toilet (shared with other household) 2 
Traditional pit toilet/ latrine 3 
Ventilated improved pit latrine 4 
No facility/ Bush/ Field 5 
Other : Please specify 6 








20. What is the principal flooring material in your house? 
Earth/ dirt/sand/dung 1 
Cement 2 
Vinyl or asphalt tile 3 
Ceramic tiles 4 
Parquet or polished wood 5 
Other, please specify 6 
21. What is the main material in the walls? 
Thatched 1 
Mud and pole 2 
Un burnt bricks 3 
Burnt bricks with mud 4 
Burnt bricks with cement 5 
Timber 6 
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Cement blocks, bricks, concrete walls 7 
Stone 8 
Other, please specify 9 
22. What is the principal roofing material in your house? 
Thatched 1 





Other, please specify 7 
23. Does any member of your household own ......... ? 
A bicycle 1 
A motorcycle or motor scooter 2 
A car or truck 3 
A boat or canoe 4 
A donkey 5 






Others please specify 







26. How did you know about provision of free ARV's 
Friends/family 
Posters at clinic 2 
Newspapers 3 
Leaflets 4 
Clinic personnel 5 
Community health worker/health educator 6 
Radio 7 
TV 8 
Other, please specify 
27. How were you enrolled on this programme? 
28. When did you start receiving treatment on this programme? 
29. Do you think these ARV drugs help? Yes/ No 
If yes, why do you think so? 
If No, why do you think so? 
30. How many times do you come to receive drugs at the facility? 
Once a week 
Once in a fortnight 2 
Once a month 3 
31. Are you the only one receiving free drugs in your household? 
Yes 1 Skip to qn 30 
No 2 Go to qn 29 
32. How many other people in your family are receiving free ARVs? 
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33. Are you the only one who needs these drugs in the household? 
Yes 1 Skip to 32 
No 2 Go to On 31 
34. What do you think could be the factors constraining accessibility of these drugs for members of your 
household that need them _________ _ 
35. What are the benefits you get from these programmes? _________ _ 
36. Do you incur any costs in accessing these drugs? 
I ::· I : I ~:;~:~; 
37. What are the costs? 
Consultation fee 1 
Payment for drugs 2 
Laboratory test fees 3 
Other costs, please spec~y 
38. Do you think that whoever needs these free drugs get access to them? 
Yes 1 End 
No 2 Go to On 39 
39. What do you think are the factors that constrain others from accessing the drugs? 
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APPENDIX E: Focus Group Discussion (FGD) 
There will be discussions with representatives of the communities within selected 
areas. It is expected to discuss with religion leaders, community leaders and 
other representatives in case of any other available groups in the selected areas. 
A brief introduction about the research project will be given to the group 
discussion and the verbal consent form will be obtained from all participants 
Suggested Questions: 
What do you know about antiretroviral drugs? 
What benefits do you think are obtained from receiving antiretroviral drugs? 
Do you know whether ARVs are provided free or at a low cost in any facility in 
your community? 
Who do you think is eligible to access free or low cost ARVs? 
Which groups of people do you think benefit more from these services? Why? 
Do you think whoever need to use ARVs can access them? 
What factors do you think would encourage or discourage people from accessing 
antiretroviral drugs? 
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